data_1xoo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xoo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.3 p . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tt -58.55 -36.32 73.71 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.144 0.497 . . . . 0.0 110.517 169.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.49 -44.44 94.33 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.628 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.39 -48.16 42.02 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.265 0.936 . . . . 0.0 111.704 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.58 75.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.786 1.293 . . . . 0.0 112.604 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.263 98.1 mt -63.95 -92.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.704 2.002 . . . . 0.0 108.75 166.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.41 -42.79 15.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.93 2.092 . . . . 0.0 112.273 -170.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.1 -23.04 71.14 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 119.44 1.018 . . . . 0.0 113.59 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -46.71 50.24 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.818 1.309 . . . . 0.0 109.415 167.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mt -57.84 -43.75 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.537 1.535 . . . . 0.0 108.553 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -57.19 -2.75 0.11 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.253 1.421 . . . . 0.0 114.342 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.1 -54.66 1.49 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.088 1.355 . . . . 0.0 110.634 158.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.93 -8.17 87.97 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.029 -0.873 . . . . 0.0 114.513 -166.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 18.4 t90 -56.01 -47.51 77.64 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.511 1.155 . . . . 0.0 111.203 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.28 -18.87 61.77 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.65 0.594 . . . . 0.0 112.235 -161.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.63 -3.94 90.3 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.206 -0.774 . . . . 0.0 113.085 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 89.0 mmm -129.0 9.28 5.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.375 1.87 . . . . 0.0 111.84 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm . . . . . 0 N--CA 1.466 0.341 0 C-N-CA 124.831 1.252 . . . . 0.0 110.145 -177.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.45 -34.18 73.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.206 0.527 . . . . 0.0 110.468 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -63.3 -44.22 95.63 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.778 173.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.45 -48.67 41.27 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.013 -0.882 . . . . 0.0 111.553 167.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.13 84.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.798 1.299 . . . . 0.0 112.529 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.285 96.8 mt -58.42 -92.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.991 2.116 . . . . 0.0 109.152 166.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.86 -37.05 8.18 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.819 2.048 . . . . 0.0 113.168 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.01 -18.86 79.77 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.573 1.082 . . . . 0.0 113.967 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.87 -48.1 19.33 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.983 1.392 . . . . 0.0 108.796 161.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.85 -43.61 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.322 1.449 . . . . 0.0 109.278 -173.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.74 -0.95 0.33 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 120.236 1.38 . . . . 0.0 114.4 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -122.62 -56.73 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.912 1.285 . . . . 0.0 110.45 159.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.79 -8.31 87.8 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.899 -0.945 . . . . 0.0 114.801 -166.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -55.59 -48.8 74.24 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.83 1.252 . . . . 0.0 111.018 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -75.42 -15.79 60.41 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.746 -159.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.3 -2.03 83.39 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.139 -0.812 . . . . 0.0 112.959 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 92.0 mmm -125.81 5.26 7.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.838 1.655 . . . . 0.0 111.973 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mm . . . . . 0 CA--C 1.532 0.286 0 C-N-CA 124.696 1.199 . . . . 0.0 110.115 -178.847 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 tt -58.42 -36.55 73.78 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.043 0.537 . . . . 0.0 110.914 170.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.37 -41.07 89.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.814 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.46 -48.37 65.17 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 119.101 -0.833 . . . . 0.0 111.406 165.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.37 -32.05 73.37 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.586 1.193 . . . . 0.0 112.473 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.273 95.9 mt -60.63 -92.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.774 2.03 . . . . 0.0 108.279 162.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -51.14 -39.28 55.91 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.231 1.813 . . . . 0.0 113.304 -165.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.92 -17.49 79.38 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.339 0.971 . . . . 0.0 113.549 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.17 -50.59 9.41 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.44 1.12 . . . . 0.0 108.737 162.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mt -56.63 -40.33 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 125.694 1.598 . . . . 0.0 110.307 -173.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.01 -3.03 0.49 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.799 1.181 . . . . 0.0 113.96 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -123.97 -60.52 1.43 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.332 1.453 . . . . 0.0 110.385 159.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.62 84.36 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.535 1.064 . . . . 0.0 114.582 -164.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 t90 -53.31 -41.79 66.03 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.379 1.09 . . . . 0.0 111.543 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.04 -36.63 84.21 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.749 0.656 . . . . 0.0 111.269 -164.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.17 -1.11 62.86 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.798 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 mmt -119.48 3.33 11.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.08 1.752 . . . . 0.0 111.706 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm . . . . . 0 C--N 1.342 0.281 0 C-N-CA 123.782 0.833 . . . . 0.0 109.264 177.928 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.5 p . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -32.72 72.33 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 170.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -60.83 -47.01 88.29 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 122.969 0.508 . . . . 0.0 110.774 172.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.37 -48.68 47.47 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.873 0.749 . . . . 0.0 111.565 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.02 -20.27 65.79 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.5 mt -86.12 -93.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 126.4 1.88 . . . . 0.0 108.004 168.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.54 79.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.432 2.293 . . . . 0.0 112.614 -169.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.79 -38.73 66.15 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 119.13 0.877 . . . . 0.0 111.845 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -44.65 93.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.876 0.87 . . . . 0.0 110.419 167.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.01 -53.41 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 124.681 1.192 . . . . 0.0 108.754 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -70.64 63.88 0.28 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.964 1.706 . . . . 0.0 111.626 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.9 -61.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 129.249 3.02 . . . . 0.0 108.646 -163.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.26 -4.27 4.09 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.059 1.314 . . . . 0.0 113.573 -168.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -46.38 -40.11 11.46 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 126.168 1.787 . . . . 0.0 110.807 170.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.07 -19.47 65.66 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.783 0.677 . . . . 0.0 112.106 -172.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.22 2.02 83.13 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.063 0.84 . . . . 0.0 112.959 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.6 mmt -128.2 6.54 5.9 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.083 2.153 . . . . 0.0 111.464 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 mm . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.835 1.254 . . . . 0.0 109.85 177.473 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.4 p . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.93 -34.16 72.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.844 0.458 . . . . 0.0 110.321 170.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -62.83 -44.39 96.28 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 122.977 0.511 . . . . 0.0 110.672 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.52 -47.76 50.77 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.949 -0.917 . . . . 0.0 111.479 168.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.99 91.87 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.542 1.171 . . . . 0.0 112.434 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.287 96.6 mt -56.55 -92.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.884 2.073 . . . . 0.0 109.017 165.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.0 -37.26 3.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 127.403 2.281 . . . . 0.0 113.131 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.06 -28.37 73.0 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.683 1.129 . . . . 0.0 113.601 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.66 -39.04 67.45 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.899 1.35 . . . . 0.0 109.733 168.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -68.09 -49.7 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.39 55.91 0.82 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.984 1.265 . . . . 0.0 110.634 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.63 -67.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.666 3.986 . . . . 0.0 107.234 -161.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.54 -5.38 16.4 Favored Glycine 0 C--N 1.345 1.067 0 C-N-CA 124.65 1.119 . . . . 0.0 114.284 -166.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -48.02 -45.45 31.9 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.717 1.607 . . . . 0.0 109.854 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.84 -23.96 65.22 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 124.525 1.141 . . . . 0.0 111.441 -166.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.09 -10.05 80.83 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.583 -1.121 . . . . 0.0 113.268 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.4 mmm -122.07 12.61 10.39 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.503 1.521 . . . . 0.0 111.942 -173.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 mm . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.259 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.8 p . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.05 -32.56 72.19 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 170.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -59.33 -46.67 87.96 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.151 0.58 . . . . 0.0 110.889 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.93 -44.13 55.67 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.088 -0.84 . . . . 0.0 111.99 170.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.73 -32.37 73.63 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.742 1.271 . . . . 0.0 112.718 176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.0 mt -70.36 -92.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.819 2.047 . . . . 0.0 108.571 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.49 -43.26 55.55 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.506 1.922 . . . . 0.0 111.567 -172.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.78 -21.78 73.3 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.583 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -71.75 -51.14 24.31 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.134 1.467 . . . . 0.0 109.079 165.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.07 -44.01 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 125.733 1.613 . . . . 0.0 109.019 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.49 -3.98 0.13 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.433 1.493 . . . . 0.0 114.278 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.53 -56.25 1.4 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.171 1.389 . . . . 0.0 110.849 158.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.86 -7.28 88.4 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.398 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.5 t90 -53.56 -51.44 62.91 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 124.668 1.187 . . . . 0.0 110.852 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.81 -20.08 61.9 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 123.918 0.761 . . . . 0.0 111.638 -163.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.43 -5.94 89.55 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.409 -1.217 . . . . 0.0 113.209 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.3 mmm -128.1 16.3 6.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.425 1.89 . . . . 0.0 111.838 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mm . . . . . 0 CA--C 1.54 0.575 0 C-N-CA 123.894 0.878 . . . . 0.0 110.802 -179.383 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.87 -34.78 73.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.711 0.404 . . . . 0.0 110.119 170.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.82 -45.64 92.95 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.65 0.38 . . . . 0.0 110.689 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.98 -48.79 37.67 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.174 0.892 . . . . 0.0 111.609 168.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.78 76.33 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.233 1.016 . . . . 0.0 112.784 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.257 96.5 mt -65.27 -92.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.59 1.956 . . . . 0.0 108.555 167.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.54 -39.36 48.95 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.527 1.931 . . . . 0.0 112.318 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.32 -22.86 77.68 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.574 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -71.75 -48.25 48.1 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.16 1.48 . . . . 0.0 109.076 164.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -59.19 -45.36 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 C-N-CA 125.213 1.405 . . . . 0.0 108.822 -173.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -61.89 4.72 0.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.106 1.321 . . . . 0.0 114.252 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.86 -54.85 1.4 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.721 1.608 . . . . 0.0 109.872 158.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.82 -10.74 84.73 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.967 -0.907 . . . . 0.0 114.496 -167.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -56.86 -53.53 56.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.169 1.388 . . . . 0.0 110.429 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -69.83 -29.61 66.92 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.902 0.751 . . . . 0.0 110.745 -161.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.31 4.84 46.93 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.242 -1.31 . . . . 0.0 113.832 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 70.2 mtp -132.9 11.83 4.32 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.317 1.447 . . . . 0.0 112.204 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 mm . . . . . 0 CA--C 1.538 0.501 0 CA-C-N 119.219 0.918 . . . . 0.0 110.474 -179.229 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -30.85 71.89 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 171.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -56.7 -43.76 80.84 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.436 0.695 . . . . 0.0 110.676 170.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.34 -21.12 46.97 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.875 1.226 . . . . 0.0 114.313 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.25 -19.96 20.24 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.634 1.717 . . . . 0.0 112.322 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.1 mt -86.1 -93.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.009 2.124 . . . . 0.0 107.126 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.74 -43.14 80.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.117 1.767 . . . . 0.0 110.397 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.29 -21.17 71.97 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.682 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -76.51 -52.42 9.81 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.781 1.291 . . . . 0.0 109.427 165.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mt -54.87 -41.69 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 126.048 1.739 . . . . 0.0 109.382 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -59.1 -2.65 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.15 -56.61 1.43 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.54 1.536 . . . . 0.0 110.504 158.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.79 -2.67 88.62 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.283 0.944 . . . . 0.0 114.609 -166.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -57.08 -49.02 77.15 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 118.471 1.135 . . . . 0.0 110.947 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.26 -33.72 75.93 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 123.686 0.616 . . . . 0.0 110.937 -163.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.86 4.48 45.14 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.665 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -133.13 12.99 4.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.216 1.806 . . . . 0.0 111.463 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm . . . . . 0 CA--C 1.538 0.483 0 O-C-N 121.344 -0.848 . . . . 0.0 110.427 178.904 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -32.76 72.01 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.13 -46.89 82.16 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.877 -0.515 . . . . 0.0 110.705 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.46 -49.43 39.13 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.983 0.801 . . . . 0.0 111.237 169.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.95 -35.05 78.86 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 117.995 0.898 . . . . 0.0 112.581 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.267 74.7 mt -63.63 -92.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 126.78 2.032 . . . . 0.0 108.575 167.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.45 -41.45 20.5 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.854 2.062 . . . . 0.0 112.091 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.8 -25.39 71.79 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 119.832 1.196 . . . . 0.0 113.916 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -41.24 61.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.898 1.349 . . . . 0.0 109.849 169.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.94 -48.05 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 124.959 1.304 . . . . 0.0 108.03 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.7 42.65 0.06 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 127.044 2.137 . . . . 0.0 112.633 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -160.7 -65.46 0.06 Allowed 'General case' 0 N--CA 1.452 -0.358 1 C-N-CA 132.664 4.386 . . . . 0.0 106.805 -176.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.91 -7.25 25.56 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 118.931 -0.927 . . . . 0.0 114.201 -165.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -47.82 -43.87 28.35 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.336 1.454 . . . . 0.0 110.553 174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.03 -12.34 60.59 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.021 0.826 . . . . 0.0 111.987 -166.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.38 -0.65 72.99 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.999 0.809 . . . . 0.0 112.867 168.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 91.8 mmm -129.59 8.86 5.43 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.095 2.158 . . . . 0.0 111.922 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mm . . . . . 0 N--CA 1.465 0.303 0 C-N-CA 125.203 1.401 . . . . 0.0 110.289 -177.205 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.29 -33.65 73.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.785 0.326 . . . . 0.0 110.328 172.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -63.61 -44.42 94.01 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.731 0.413 . . . . 0.0 110.933 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.61 -49.06 47.98 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.207 168.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.77 83.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.06 0.93 . . . . 0.0 112.521 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.293 90.1 mt -57.11 -92.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.957 2.103 . . . . 0.0 108.953 164.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.05 -38.26 7.72 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.773 2.029 . . . . 0.0 113.064 -170.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.5 -25.06 76.28 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.829 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.81 -36.86 62.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.033 1.416 . . . . 0.0 110.004 168.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -70.02 -54.59 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 125.148 1.379 . . . . 0.0 108.537 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.4 69.54 0.39 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.487 1.915 . . . . 0.0 110.906 -172.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.34 -59.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 127.694 2.398 . . . . 0.0 108.689 -160.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.09 4.81 0.24 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.123 1.344 . . . . 0.0 112.863 -164.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -43.15 -38.95 2.64 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 126.391 1.876 . . . . 0.0 111.481 165.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.77 -34.05 77.02 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.916 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.5 -9.4 73.58 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.577 1.084 . . . . 0.0 113.049 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.2 mmm -102.18 3.84 38.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.428 1.491 . . . . 0.0 111.232 169.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 p . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.38 -32.86 71.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.637 0.375 . . . . 0.0 110.088 170.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -61.81 -47.2 86.2 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.048 0.539 . . . . 0.0 110.841 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.88 -49.94 33.84 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.059 0.838 . . . . 0.0 111.342 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.42 -21.49 66.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.187 0.993 . . . . 0.0 113.542 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.25 77.4 mt -82.24 -92.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 126.941 2.096 . . . . 0.0 107.708 169.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.66 -39.56 17.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.3 2.24 . . . . 0.0 112.933 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.01 -14.42 82.24 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.993 0.806 . . . . 0.0 113.715 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -45.55 13.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.462 1.131 . . . . 0.0 108.551 163.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.29 -42.91 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 C-N-CA 125.369 1.468 . . . . 0.0 109.2 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.14 0.11 0.19 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.29 -55.29 1.45 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.306 1.442 . . . . 0.0 110.545 159.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.41 -9.05 87.07 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.12 -0.822 . . . . 0.0 114.535 -166.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -59.87 -56.0 27.15 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.905 1.282 . . . . 0.0 111.004 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.73 -25.64 63.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.887 -158.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.44 -1.43 76.03 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.555 -1.136 . . . . 0.0 113.698 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.3 mtm -135.95 22.49 3.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.061 1.745 . . . . 0.0 111.476 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 124.084 0.954 . . . . 0.0 110.709 178.651 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -32.43 73.01 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 171.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.78 -45.75 91.22 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 121.936 -0.478 . . . . 0.0 110.701 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.34 -48.92 39.91 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.189 0.9 . . . . 0.0 111.53 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.21 -32.55 73.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.577 1.188 . . . . 0.0 112.67 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.262 68.5 mt -68.75 -92.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.869 2.068 . . . . 0.0 108.585 169.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.51 -38.49 20.37 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 127.082 2.153 . . . . 0.0 113.117 -172.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.26 79.84 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.065 0.84 . . . . 0.0 113.818 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -78.34 -50.02 12.55 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.79 1.295 . . . . 0.0 108.639 161.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.88 -41.82 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 125.284 1.434 . . . . 0.0 110.115 -173.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.17 -1.63 0.34 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.207 1.367 . . . . 0.0 114.459 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.13 -58.04 1.38 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.002 1.321 . . . . 0.0 110.575 159.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.88 -6.87 87.43 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.392 -165.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -54.14 -52.78 60.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.616 1.167 . . . . 0.0 111.01 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.36 -22.65 62.76 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.843 0.714 . . . . 0.0 111.495 -162.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.7 -0.59 89.51 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.36 -1.244 . . . . 0.0 113.446 173.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.1 mtt -137.96 23.05 2.84 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.619 1.568 . . . . 0.0 111.31 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mm . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 124.503 1.121 . . . . 0.0 110.929 179.244 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.21 -37.77 75.47 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 110.267 169.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.83 -45.17 90.65 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.219 0.533 . . . . 0.0 110.529 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.82 -36.09 59.33 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.703 1.144 . . . . 0.0 113.067 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.21 -27.5 53.5 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.377 1.589 . . . . 0.0 112.579 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -85.99 -93.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.398 1.879 . . . . 0.0 108.461 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.13 -38.22 76.09 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.034 1.734 . . . . 0.0 110.631 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.02 -22.52 75.93 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.862 -0.965 . . . . 0.0 113.463 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.81 -48.96 33.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.009 1.405 . . . . 0.0 109.165 165.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 12' ' ' ASN . 1.9 mt -58.91 -44.63 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 125.314 1.446 . . . . 0.0 108.729 -173.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -64.72 9.47 0.09 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 120.317 1.417 . . . . 0.0 114.099 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 10' ' ' ILE . 1.1 m-80 -128.13 -56.4 1.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.908 2.083 . . . . 0.0 109.364 158.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.1 -9.68 84.87 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.254 -0.748 . . . . 0.0 114.67 -166.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -58.01 -45.89 86.15 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 125.213 1.405 . . . . 0.0 110.988 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.44 -32.8 74.39 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 123.842 0.714 . . . . 0.0 111.035 -163.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.71 1.69 51.87 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.626 -1.097 . . . . 0.0 113.687 174.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.42 15.16 5.01 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.401 1.88 . . . . 0.0 111.212 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 mm . . . . . 0 CA--C 1.537 0.447 0 O-C-N 121.326 -0.859 . . . . 0.0 109.486 175.91 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.83 -32.6 71.98 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 170.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -62.77 -47.28 84.17 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 122.035 -0.416 . . . . 0.0 110.81 173.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.16 -48.9 38.67 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 123.98 0.8 . . . . 0.0 111.254 169.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.35 77.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.924 0.862 . . . . 0.0 112.764 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.268 70.8 mt -62.55 -92.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.82 2.048 . . . . 0.0 108.492 166.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.81 -40.51 29.45 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.707 2.003 . . . . 0.0 112.48 -169.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.14 77.19 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 119.737 1.153 . . . . 0.0 113.377 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -37.61 83.09 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.711 1.256 . . . . 0.0 110.107 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mt -69.02 -54.4 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 C-N-CA 125.211 1.404 . . . . 0.0 108.678 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.82 59.82 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 129.16 2.984 . . . . 0.0 112.291 -173.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -172.18 -64.86 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.745 2.418 . . . . 0.0 108.603 -162.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.53 -1.9 1.59 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.89 1.233 . . . . 0.0 113.412 -166.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -40.37 -45.91 2.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 126.086 1.754 . . . . 0.0 111.189 168.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.75 -14.97 62.64 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.2 0.937 . . . . 0.0 112.071 -170.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.48 4.37 76.48 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.449 1.023 . . . . 0.0 112.806 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.9 mtm -135.04 17.6 3.47 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.083 2.153 . . . . 0.0 111.118 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mm . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 124.944 1.298 . . . . 0.0 110.863 -178.583 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.48 -33.6 72.83 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 171.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.5 -47.08 85.53 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 122.682 0.393 . . . . 0.0 110.815 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.14 -46.12 56.7 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.404 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.66 -35.88 82.0 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.474 1.137 . . . . 0.0 112.459 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.276 86.0 mt -60.35 -92.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.635 1.974 . . . . 0.0 108.568 165.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.67 -40.4 9.11 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.281 2.232 . . . . 0.0 112.568 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.23 -28.95 74.16 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.859 1.208 . . . . 0.0 113.673 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -37.7 77.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.935 1.367 . . . . 0.0 109.906 170.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mt -68.3 -52.47 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 125.026 1.331 . . . . 0.0 108.431 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.62 54.56 0.08 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.176 2.59 . . . . 0.0 112.357 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -175.03 -69.09 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 129.558 3.143 . . . . 0.0 108.038 -163.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.13 -4.71 9.17 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 124.792 1.187 . . . . 0.0 113.852 -167.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -44.04 -45.14 7.82 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 125.964 1.706 . . . . 0.0 111.097 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.08 -11.14 60.44 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.073 0.858 . . . . 0.0 112.067 -169.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.93 2.64 69.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.212 0.911 . . . . 0.0 112.797 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.9 mmt -130.6 8.04 4.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.697 1.999 . . . . 0.0 111.474 -172.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mm . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 125.323 1.449 . . . . 0.0 110.166 -179.437 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.77 -33.13 72.49 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.171 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -63.93 -45.49 89.0 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 122.587 0.355 . . . . 0.0 110.715 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.86 -47.9 38.43 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.451 168.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.16 -41.86 98.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.587 1.193 . . . . 0.0 112.303 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.295 89.9 mt -54.88 -92.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 127.157 2.183 . . . . 0.0 109.391 167.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -44.62 -42.15 7.2 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.604 1.961 . . . . 0.0 112.622 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.35 -26.63 74.15 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.573 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -69.07 -50.45 48.26 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.266 1.533 . . . . 0.0 109.036 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mt -56.6 -42.8 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 125.262 1.425 . . . . 0.0 109.369 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -59.16 -2.25 0.26 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.0 -57.7 1.31 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.109 1.363 . . . . 0.0 110.748 159.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.87 -5.05 89.64 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.882 -0.954 . . . . 0.0 114.414 -165.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -55.61 -53.68 53.48 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 118.545 1.172 . . . . 0.0 110.881 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.01 -24.46 61.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.342 -164.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.69 10.96 28.69 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.503 1.525 . . . . 0.0 113.593 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.0 mmt -124.65 -10.95 7.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.828 1.251 . . . . 0.0 112.786 165.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mm . . . . . 0 CA--C 1.532 0.256 0 C-N-CA 125.212 1.405 . . . . 0.0 110.91 179.353 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.09 -34.31 73.29 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.121 0.569 . . . . 0.0 110.751 171.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.93 -45.63 91.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.786 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.43 -48.14 49.28 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.295 168.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.37 -34.24 77.29 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.491 1.146 . . . . 0.0 112.852 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.28 96.5 mt -60.72 -92.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.693 1.997 . . . . 0.0 108.648 164.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.45 -36.99 7.14 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.165 2.186 . . . . 0.0 113.266 -170.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.16 -26.21 72.79 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.453 1.024 . . . . 0.0 113.703 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -38.15 73.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.118 1.459 . . . . 0.0 109.46 167.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.17 -56.19 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 124.937 1.295 . . . . 0.0 110.141 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -68.86 65.38 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.83 2.852 . . . . 0.0 110.691 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.94 -51.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.349 1.86 . . . . 0.0 109.017 -163.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.88 -4.19 0.07 OUTLIER Glycine 0 C--N 1.34 0.775 0 CA-C-O 117.604 -1.665 . . . . 0.0 115.011 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.81 -36.62 72.47 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 120.162 1.981 . . . . 0.0 110.042 173.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.4 -29.82 70.17 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.489 -173.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.21 7.72 21.61 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.857 1.218 . . . . 0.0 113.845 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 48.0 mtt -130.53 6.62 4.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.26 1.424 . . . . 0.0 111.879 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.3 mm . . . . . 0 CA--C 1.533 0.313 0 C-N-CA 123.974 0.91 . . . . 0.0 111.21 -175.55 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -32.78 73.81 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 170.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -55.58 -45.68 77.33 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.695 0.798 . . . . 0.0 110.872 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.23 -24.37 55.15 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.581 -1.122 . . . . 0.0 114.04 172.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.83 -18.1 30.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.571 1.686 . . . . 0.0 112.356 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.0 mt -86.29 -93.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 126.951 2.1 . . . . 0.0 107.474 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.28 -45.5 72.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.372 1.869 . . . . 0.0 110.522 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.3 -13.61 65.25 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 119.004 0.82 . . . . 0.0 114.272 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.03 -46.28 13.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.754 1.277 . . . . 0.0 109.583 164.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -54.76 -51.94 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.058 1.743 . . . . 0.0 111.171 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -67.1 47.87 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 130.871 3.668 . . . . 0.0 113.314 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -145.17 -56.06 0.32 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.193 2.197 . . . . 0.0 109.296 -172.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.36 -4.82 0.45 Allowed Glycine 0 C--N 1.341 0.822 0 CA-C-O 118.047 -1.418 . . . . 0.0 114.112 -170.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -31.51 65.71 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 119.589 1.694 . . . . 0.0 110.756 173.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.92 -30.67 68.01 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.88 0.872 . . . . 0.0 111.748 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.71 8.91 12.31 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.905 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.6 mtt -130.5 5.89 4.77 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.693 1.597 . . . . 0.0 112.001 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.6 mm . . . . . 0 CA--C 1.533 0.307 0 C-N-CA 124.084 0.954 . . . . 0.0 111.417 -175.49 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.96 -35.15 74.34 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.007 0.432 . . . . 0.0 110.472 171.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.31 -46.02 90.61 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.635 173.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.0 -46.8 49.98 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.487 168.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.08 -34.83 78.93 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.671 1.236 . . . . 0.0 112.652 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.274 97.2 mt -61.86 -92.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.811 2.044 . . . . 0.0 109.023 166.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.24 -42.75 21.02 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.333 1.853 . . . . 0.0 112.077 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.27 -23.24 76.38 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 119.573 1.079 . . . . 0.0 113.612 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.62 -49.17 50.46 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.153 1.477 . . . . 0.0 108.992 165.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mt -55.23 -45.54 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 125.293 1.437 . . . . 0.0 108.932 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -57.11 -1.21 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.59 1.556 . . . . 0.0 114.36 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -125.29 -56.61 1.52 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.123 1.369 . . . . 0.0 110.334 158.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.11 -8.33 87.47 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.056 -0.858 . . . . 0.0 114.666 -165.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -53.45 -57.0 12.21 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 125.526 1.53 . . . . 0.0 110.381 175.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.32 3.49 2.88 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -158.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.15 2.24 59.53 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.331 -1.26 . . . . 0.0 113.644 166.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.8 mtm -125.7 -7.52 6.78 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.428 1.614 . . . . 0.0 115.344 -167.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.0 mp . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 124.835 1.254 . . . . 0.0 110.294 -179.021 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 tt -58.08 -36.81 73.38 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.073 0.549 . . . . 0.0 110.572 168.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.24 -46.16 90.74 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.719 173.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.85 -46.5 48.88 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.957 -0.913 . . . . 0.0 112.074 169.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.01 -25.27 67.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.773 1.286 . . . . 0.0 113.039 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.12 -92.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 126.662 1.985 . . . . 0.0 107.972 167.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.81 -42.06 16.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.542 2.337 . . . . 0.0 112.615 -171.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.65 -14.4 77.86 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.409 1.004 . . . . 0.0 113.943 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -40.5 23.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.77 1.285 . . . . 0.0 109.462 163.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.58 -53.05 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.449 1.5 . . . . 0.0 111.293 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.3 64.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.824 2.85 . . . . 0.0 111.949 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -160.54 -54.53 0.05 Allowed 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 126.817 2.047 . . . . 0.0 110.02 -167.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.46 10.58 0.06 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.593 -1.115 . . . . 0.0 113.391 -171.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -20.29 46.55 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.455 1.627 . . . . 0.0 111.753 172.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -54.36 -31.69 55.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.863 1.265 . . . . 0.0 111.368 173.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.57 -11.26 47.72 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.51 -0.744 . . . . 0.0 113.507 173.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.0 mmm -109.54 -3.63 16.81 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.46 1.904 . . . . 0.0 112.243 171.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 CA--C 1.534 0.336 0 C-N-CA 125.296 1.438 . . . . 0.0 108.637 167.063 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.3 p . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tt -58.55 -36.32 73.71 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.144 0.497 . . . . 0.0 110.517 169.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.49 -44.44 94.33 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.628 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.39 -48.16 42.02 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.265 0.936 . . . . 0.0 111.704 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.58 75.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.786 1.293 . . . . 0.0 112.604 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.263 98.1 mt -63.95 -92.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.704 2.002 . . . . 0.0 108.75 166.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.41 -42.79 15.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.93 2.092 . . . . 0.0 112.273 -170.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.1 -23.04 71.14 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 119.44 1.018 . . . . 0.0 113.59 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -46.71 50.24 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.818 1.309 . . . . 0.0 109.415 167.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.6 mt -57.84 -43.75 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.537 1.535 . . . . 0.0 108.553 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -57.19 -2.75 0.11 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.253 1.421 . . . . 0.0 114.342 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.1 -54.66 1.49 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.088 1.355 . . . . 0.0 110.634 158.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.93 -8.17 87.97 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.029 -0.873 . . . . 0.0 114.513 -166.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 18.4 t90 -56.01 -47.51 77.64 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.511 1.155 . . . . 0.0 111.203 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.28 -18.87 61.77 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.65 0.594 . . . . 0.0 112.235 -161.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.63 -3.94 90.3 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.206 -0.774 . . . . 0.0 113.085 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 89.0 mmm -129.0 9.28 5.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.375 1.87 . . . . 0.0 111.84 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.446 ' C ' ' H ' ' A' ' 20' ' ' GLY . 4.1 mm -55.33 -45.64 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.831 1.252 . . . . 0.0 110.145 -177.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.72 19.06 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.458 2.703 . . . . 0.0 113.551 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 18' ' ' ILE . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 125.673 1.606 . . . . 0.0 114.486 -172.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.45 -34.18 73.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.206 0.527 . . . . 0.0 110.468 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -63.3 -44.22 95.63 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.778 173.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.45 -48.67 41.27 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.013 -0.882 . . . . 0.0 111.553 167.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.13 84.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.798 1.299 . . . . 0.0 112.529 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.285 96.8 mt -58.42 -92.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.991 2.116 . . . . 0.0 109.152 166.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.86 -37.05 8.18 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.819 2.048 . . . . 0.0 113.168 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.01 -18.86 79.77 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.573 1.082 . . . . 0.0 113.967 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.87 -48.1 19.33 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.983 1.392 . . . . 0.0 108.796 161.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.85 -43.61 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.322 1.449 . . . . 0.0 109.278 -173.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.74 -0.95 0.33 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 120.236 1.38 . . . . 0.0 114.4 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -122.62 -56.73 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.912 1.285 . . . . 0.0 110.45 159.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.79 -8.31 87.8 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.899 -0.945 . . . . 0.0 114.801 -166.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 18.6 t90 -55.59 -48.8 74.24 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.83 1.252 . . . . 0.0 111.018 178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -75.42 -15.79 60.41 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.746 -159.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.3 -2.03 83.39 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.139 -0.812 . . . . 0.0 112.959 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 92.0 mmm -125.81 5.26 7.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.838 1.655 . . . . 0.0 111.973 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.427 ' C ' ' H ' ' A' ' 20' ' ' GLY . 6.8 mm -55.98 -45.09 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.696 1.199 . . . . 0.0 110.115 -178.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.78 18.98 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.757 2.823 . . . . 0.0 113.972 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.427 ' H ' ' C ' ' A' ' 18' ' ' ILE . . . . . . . . 0 CA--C 1.532 1.141 0 C-N-CA 125.166 1.365 . . . . 0.0 114.48 -173.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 tt -58.42 -36.55 73.78 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.043 0.537 . . . . 0.0 110.914 170.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.37 -41.07 89.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.814 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.46 -48.37 65.17 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 119.101 -0.833 . . . . 0.0 111.406 165.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.37 -32.05 73.37 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.586 1.193 . . . . 0.0 112.473 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.273 95.9 mt -60.63 -92.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.774 2.03 . . . . 0.0 108.279 162.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -51.14 -39.28 55.91 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.231 1.813 . . . . 0.0 113.304 -165.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.92 -17.49 79.38 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.339 0.971 . . . . 0.0 113.549 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.17 -50.59 9.41 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.44 1.12 . . . . 0.0 108.737 162.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mt -56.63 -40.33 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 125.694 1.598 . . . . 0.0 110.307 -173.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.01 -3.03 0.49 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.799 1.181 . . . . 0.0 113.96 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -123.97 -60.52 1.43 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.332 1.453 . . . . 0.0 110.385 159.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.62 84.36 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.535 1.064 . . . . 0.0 114.582 -164.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 t90 -53.31 -41.79 66.03 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.379 1.09 . . . . 0.0 111.543 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.04 -36.63 84.21 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.749 0.656 . . . . 0.0 111.269 -164.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.17 -1.11 62.86 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.798 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 mmt -119.48 3.33 11.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.08 1.752 . . . . 0.0 111.706 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.451 ' C ' ' H ' ' A' ' 20' ' ' GLY . 5.9 mm -57.87 -48.72 83.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 123.782 0.833 . . . . 0.0 109.264 177.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.51 19.35 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.334 2.654 . . . . 0.0 113.407 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.451 ' H ' ' C ' ' A' ' 18' ' ' ILE . . . . . . . . 0 CA--C 1.532 1.152 0 C-N-CA 125.265 1.412 . . . . 0.0 114.711 -170.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.5 p . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -32.72 72.33 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 170.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -60.83 -47.01 88.29 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 122.969 0.508 . . . . 0.0 110.774 172.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.37 -48.68 47.47 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.873 0.749 . . . . 0.0 111.565 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.02 -20.27 65.79 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.5 mt -86.12 -93.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 126.4 1.88 . . . . 0.0 108.004 168.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.54 79.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.432 2.293 . . . . 0.0 112.614 -169.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.79 -38.73 66.15 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 119.13 0.877 . . . . 0.0 111.845 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -44.65 93.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.876 0.87 . . . . 0.0 110.419 167.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.01 -53.41 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 124.681 1.192 . . . . 0.0 108.754 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -70.64 63.88 0.28 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.964 1.706 . . . . 0.0 111.626 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.9 -61.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 129.249 3.02 . . . . 0.0 108.646 -163.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.26 -4.27 4.09 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.059 1.314 . . . . 0.0 113.573 -168.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.3 t90 -46.38 -40.11 11.46 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 126.168 1.787 . . . . 0.0 110.807 170.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.07 -19.47 65.66 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.783 0.677 . . . . 0.0 112.106 -172.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.22 2.02 83.13 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.063 0.84 . . . . 0.0 112.959 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.6 mmt -128.2 6.54 5.9 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.083 2.153 . . . . 0.0 111.464 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.432 ' C ' ' H ' ' A' ' 20' ' ' GLY . 6.0 mm -55.95 -40.24 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.835 1.254 . . . . 0.0 109.85 177.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.83 17.87 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.77 3.228 . . . . 0.0 114.435 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 18' ' ' ILE . . . . . . . . 0 CA--C 1.532 1.108 0 C-N-CA 125.522 1.534 . . . . 0.0 114.153 -175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.4 p . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.93 -34.16 72.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.844 0.458 . . . . 0.0 110.321 170.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -62.83 -44.39 96.28 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 122.977 0.511 . . . . 0.0 110.672 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.52 -47.76 50.77 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.949 -0.917 . . . . 0.0 111.479 168.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.99 91.87 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.542 1.171 . . . . 0.0 112.434 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.287 96.6 mt -56.55 -92.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.884 2.073 . . . . 0.0 109.017 165.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.0 -37.26 3.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 127.403 2.281 . . . . 0.0 113.131 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.06 -28.37 73.0 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.683 1.129 . . . . 0.0 113.601 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.66 -39.04 67.45 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.899 1.35 . . . . 0.0 109.733 168.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -68.09 -49.7 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -175.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.39 55.91 0.82 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.984 1.265 . . . . 0.0 110.634 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.63 -67.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.666 3.986 . . . . 0.0 107.234 -161.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.54 -5.38 16.4 Favored Glycine 0 C--N 1.345 1.067 0 C-N-CA 124.65 1.119 . . . . 0.0 114.284 -166.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -48.02 -45.45 31.9 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.717 1.607 . . . . 0.0 109.854 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.84 -23.96 65.22 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 124.525 1.141 . . . . 0.0 111.441 -166.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.09 -10.05 80.83 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.583 -1.121 . . . . 0.0 113.268 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.4 mmm -122.07 12.61 10.39 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.503 1.521 . . . . 0.0 111.942 -173.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 mm -73.39 -51.29 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 p30 32.3 13.78 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 1 C-N-CA 134.191 4.997 . . . . 0.0 120.689 171.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.059 0 C-N-CA 126.401 1.953 . . . . 0.0 113.602 -179.866 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.8 p . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.05 -32.56 72.19 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 170.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -59.33 -46.67 87.96 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.151 0.58 . . . . 0.0 110.889 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.93 -44.13 55.67 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.088 -0.84 . . . . 0.0 111.99 170.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.73 -32.37 73.63 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.742 1.271 . . . . 0.0 112.718 176.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.0 mt -70.36 -92.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.819 2.047 . . . . 0.0 108.571 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.49 -43.26 55.55 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.506 1.922 . . . . 0.0 111.567 -172.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.78 -21.78 73.3 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.583 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -71.75 -51.14 24.31 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.134 1.467 . . . . 0.0 109.079 165.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.07 -44.01 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 125.733 1.613 . . . . 0.0 109.019 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.49 -3.98 0.13 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.433 1.493 . . . . 0.0 114.278 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.53 -56.25 1.4 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.171 1.389 . . . . 0.0 110.849 158.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.86 -7.28 88.4 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.398 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 20.5 t90 -53.56 -51.44 62.91 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 124.668 1.187 . . . . 0.0 110.852 177.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.81 -20.08 61.9 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 123.918 0.761 . . . . 0.0 111.638 -163.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.43 -5.94 89.55 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.409 -1.217 . . . . 0.0 113.209 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.3 mmm -128.1 16.3 6.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.425 1.89 . . . . 0.0 111.838 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mm -62.87 -31.3 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.894 0.878 . . . . 0.0 110.802 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 49.57 14.38 0.11 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 129.96 3.304 . . . . 0.0 117.156 165.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.983 0 C-N-CA 125.118 1.342 . . . . 0.0 113.641 -174.916 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.87 -34.78 73.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.711 0.404 . . . . 0.0 110.119 170.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.82 -45.64 92.95 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.65 0.38 . . . . 0.0 110.689 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.98 -48.79 37.67 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.174 0.892 . . . . 0.0 111.609 168.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.78 76.33 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.233 1.016 . . . . 0.0 112.784 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.257 96.5 mt -65.27 -92.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.59 1.956 . . . . 0.0 108.555 167.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.54 -39.36 48.95 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.527 1.931 . . . . 0.0 112.318 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.32 -22.86 77.68 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.574 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -71.75 -48.25 48.1 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.16 1.48 . . . . 0.0 109.076 164.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -59.19 -45.36 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 C-N-CA 125.213 1.405 . . . . 0.0 108.822 -173.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -61.89 4.72 0.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.106 1.321 . . . . 0.0 114.252 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.86 -54.85 1.4 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.721 1.608 . . . . 0.0 109.872 158.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.82 -10.74 84.73 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.967 -0.907 . . . . 0.0 114.496 -167.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.3 t90 -56.86 -53.53 56.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.169 1.388 . . . . 0.0 110.429 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -69.83 -29.61 66.92 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.902 0.751 . . . . 0.0 110.745 -161.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.31 4.84 46.93 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.242 -1.31 . . . . 0.0 113.832 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 70.2 mtp -132.9 11.83 4.32 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.317 1.447 . . . . 0.0 112.204 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 mm -65.73 -36.26 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.219 0.918 . . . . 0.0 110.474 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 47.82 15.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 130.65 3.58 . . . . 0.0 117.537 164.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.925 0 C-N-CA 124.854 1.216 . . . . 0.0 113.299 -171.882 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -30.85 71.89 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 171.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -56.7 -43.76 80.84 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.436 0.695 . . . . 0.0 110.676 170.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.34 -21.12 46.97 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.875 1.226 . . . . 0.0 114.313 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.25 -19.96 20.24 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.634 1.717 . . . . 0.0 112.322 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.1 mt -86.1 -93.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.009 2.124 . . . . 0.0 107.126 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.74 -43.14 80.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.117 1.767 . . . . 0.0 110.397 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.29 -21.17 71.97 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.682 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -76.51 -52.42 9.81 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.781 1.291 . . . . 0.0 109.427 165.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mt -54.87 -41.69 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 126.048 1.739 . . . . 0.0 109.382 -173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -59.1 -2.65 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.15 -56.61 1.43 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.54 1.536 . . . . 0.0 110.504 158.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.79 -2.67 88.62 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.283 0.944 . . . . 0.0 114.609 -166.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 18.0 t90 -57.08 -49.02 77.15 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 118.471 1.135 . . . . 0.0 110.947 177.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.26 -33.72 75.93 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 123.686 0.616 . . . . 0.0 110.937 -163.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.86 4.48 45.14 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.665 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -133.13 12.99 4.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.216 1.806 . . . . 0.0 111.463 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -61.48 -38.37 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 121.344 -0.848 . . . . 0.0 110.427 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 48.04 14.8 0.06 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 130.362 3.465 . . . . 0.0 117.275 166.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.896 0 C-N-CA 125.794 1.664 . . . . 0.0 113.888 -172.685 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -32.76 72.01 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.13 -46.89 82.16 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.877 -0.515 . . . . 0.0 110.705 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.46 -49.43 39.13 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.983 0.801 . . . . 0.0 111.237 169.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.95 -35.05 78.86 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 117.995 0.898 . . . . 0.0 112.581 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.267 74.7 mt -63.63 -92.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 126.78 2.032 . . . . 0.0 108.575 167.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.45 -41.45 20.5 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.854 2.062 . . . . 0.0 112.091 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.8 -25.39 71.79 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 119.832 1.196 . . . . 0.0 113.916 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -41.24 61.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.898 1.349 . . . . 0.0 109.849 169.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.94 -48.05 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 124.959 1.304 . . . . 0.0 108.03 -178.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.7 42.65 0.06 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 127.044 2.137 . . . . 0.0 112.633 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -160.7 -65.46 0.06 Allowed 'General case' 0 N--CA 1.452 -0.358 1 C-N-CA 132.664 4.386 . . . . 0.0 106.805 -176.712 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.91 -7.25 25.56 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 118.931 -0.927 . . . . 0.0 114.201 -165.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 19.6 t90 -47.82 -43.87 28.35 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.336 1.454 . . . . 0.0 110.553 174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.03 -12.34 60.59 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.021 0.826 . . . . 0.0 111.987 -166.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.38 -0.65 72.99 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.999 0.809 . . . . 0.0 112.867 168.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 91.8 mmm -129.59 8.86 5.43 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.095 2.158 . . . . 0.0 111.922 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 20' ' ' GLY . 2.9 mm -53.95 -38.0 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.203 1.401 . . . . 0.0 110.289 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.6 13.89 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.7 2.0 . . . . 0.0 113.803 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.478 ' H ' ' C ' ' A' ' 18' ' ' ILE . . . . . . . . 0 CA--C 1.535 1.293 0 C-N-CA 128.4 2.905 . . . . 0.0 111.869 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.29 -33.65 73.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.785 0.326 . . . . 0.0 110.328 172.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -63.61 -44.42 94.01 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.731 0.413 . . . . 0.0 110.933 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.61 -49.06 47.98 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.207 168.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.77 83.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.06 0.93 . . . . 0.0 112.521 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.293 90.1 mt -57.11 -92.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.957 2.103 . . . . 0.0 108.953 164.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.05 -38.26 7.72 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.773 2.029 . . . . 0.0 113.064 -170.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.5 -25.06 76.28 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.829 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.81 -36.86 62.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.033 1.416 . . . . 0.0 110.004 168.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -70.02 -54.59 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 125.148 1.379 . . . . 0.0 108.537 -174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.4 69.54 0.39 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.487 1.915 . . . . 0.0 110.906 -172.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.34 -59.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 127.694 2.398 . . . . 0.0 108.689 -160.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.09 4.81 0.24 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.123 1.344 . . . . 0.0 112.863 -164.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -43.15 -38.95 2.64 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 126.391 1.876 . . . . 0.0 111.481 165.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.77 -34.05 77.02 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.916 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.5 -9.4 73.58 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.577 1.084 . . . . 0.0 113.049 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.2 mmm -102.18 3.84 38.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.428 1.491 . . . . 0.0 111.232 169.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -104.57 -80.13 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 171.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -150.15 14.04 0.79 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.644 1.178 . . . . 0.0 112.051 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 C-N-CA 125.253 1.406 . . . . 0.0 114.24 -167.146 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 p . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.38 -32.86 71.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.637 0.375 . . . . 0.0 110.088 170.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -61.81 -47.2 86.2 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.048 0.539 . . . . 0.0 110.841 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.88 -49.94 33.84 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.059 0.838 . . . . 0.0 111.342 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.42 -21.49 66.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.187 0.993 . . . . 0.0 113.542 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.25 77.4 mt -82.24 -92.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 126.941 2.096 . . . . 0.0 107.708 169.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.66 -39.56 17.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.3 2.24 . . . . 0.0 112.933 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.01 -14.42 82.24 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.993 0.806 . . . . 0.0 113.715 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -45.55 13.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.462 1.131 . . . . 0.0 108.551 163.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.8 mt -58.29 -42.91 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 C-N-CA 125.369 1.468 . . . . 0.0 109.2 -176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.14 0.11 0.19 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.29 -55.29 1.45 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.306 1.442 . . . . 0.0 110.545 159.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.41 -9.05 87.07 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.12 -0.822 . . . . 0.0 114.535 -166.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.5 t90 -59.87 -56.0 27.15 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.905 1.282 . . . . 0.0 111.004 177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.73 -25.64 63.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.887 -158.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.44 -1.43 76.03 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.555 -1.136 . . . . 0.0 113.698 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.3 mtm -135.95 22.49 3.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.061 1.745 . . . . 0.0 111.476 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -63.03 -34.79 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.084 0.954 . . . . 0.0 110.709 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 48.9 14.29 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 130.107 3.363 . . . . 0.0 117.055 168.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 C-N-CA 126.005 1.764 . . . . 0.0 113.663 -175.575 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -32.43 73.01 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 171.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.78 -45.75 91.22 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 121.936 -0.478 . . . . 0.0 110.701 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.34 -48.92 39.91 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.189 0.9 . . . . 0.0 111.53 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.21 -32.55 73.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.577 1.188 . . . . 0.0 112.67 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.262 68.5 mt -68.75 -92.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.869 2.068 . . . . 0.0 108.585 169.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.51 -38.49 20.37 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 127.082 2.153 . . . . 0.0 113.117 -172.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.26 79.84 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.065 0.84 . . . . 0.0 113.818 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -78.34 -50.02 12.55 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.79 1.295 . . . . 0.0 108.639 161.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.88 -41.82 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 125.284 1.434 . . . . 0.0 110.115 -173.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.17 -1.63 0.34 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.207 1.367 . . . . 0.0 114.459 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.13 -58.04 1.38 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.002 1.321 . . . . 0.0 110.575 159.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.88 -6.87 87.43 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.392 -165.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -54.14 -52.78 60.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.616 1.167 . . . . 0.0 111.01 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.36 -22.65 62.76 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.843 0.714 . . . . 0.0 111.495 -162.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.7 -0.59 89.51 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.36 -1.244 . . . . 0.0 113.446 173.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.1 mtt -137.96 23.05 2.84 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.619 1.568 . . . . 0.0 111.31 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mm -58.58 -39.8 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.503 1.121 . . . . 0.0 110.929 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 46.59 14.27 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 130.977 3.711 . . . . 0.0 117.602 167.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.065 0 C-N-CA 125.58 1.562 . . . . 0.0 114.044 -176.81 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.21 -37.77 75.47 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 110.267 169.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.83 -45.17 90.65 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.219 0.533 . . . . 0.0 110.529 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.82 -36.09 59.33 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.703 1.144 . . . . 0.0 113.067 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.21 -27.5 53.5 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.377 1.589 . . . . 0.0 112.579 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -85.99 -93.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.398 1.879 . . . . 0.0 108.461 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.13 -38.22 76.09 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.034 1.734 . . . . 0.0 110.631 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.02 -22.52 75.93 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.862 -0.965 . . . . 0.0 113.463 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.81 -48.96 33.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.009 1.405 . . . . 0.0 109.165 165.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.44 ' C ' ' H ' ' A' ' 12' ' ' ASN . 1.9 mt -58.91 -44.63 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 125.314 1.446 . . . . 0.0 108.729 -173.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -64.72 9.47 0.09 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 120.317 1.417 . . . . 0.0 114.099 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 10' ' ' ILE . 1.1 m-80 -128.13 -56.4 1.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.908 2.083 . . . . 0.0 109.364 158.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.1 -9.68 84.87 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.254 -0.748 . . . . 0.0 114.67 -166.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -58.01 -45.89 86.15 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 125.213 1.405 . . . . 0.0 110.988 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.44 -32.8 74.39 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 123.842 0.714 . . . . 0.0 111.035 -163.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.71 1.69 51.87 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.626 -1.097 . . . . 0.0 113.687 174.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.42 15.16 5.01 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.401 1.88 . . . . 0.0 111.212 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 mm -67.03 -44.62 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.326 -0.859 . . . . 0.0 109.486 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 51.48 15.27 0.32 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.086 2.555 . . . . 0.0 115.786 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.072 0 C-N-CA 125.582 1.563 . . . . 0.0 113.933 -174.655 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.83 -32.6 71.98 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 170.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -62.77 -47.28 84.17 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 122.035 -0.416 . . . . 0.0 110.81 173.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.16 -48.9 38.67 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 123.98 0.8 . . . . 0.0 111.254 169.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.35 77.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.924 0.862 . . . . 0.0 112.764 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.268 70.8 mt -62.55 -92.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.82 2.048 . . . . 0.0 108.492 166.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.81 -40.51 29.45 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.707 2.003 . . . . 0.0 112.48 -169.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.14 77.19 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 119.737 1.153 . . . . 0.0 113.377 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -37.61 83.09 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.711 1.256 . . . . 0.0 110.107 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mt -69.02 -54.4 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 C-N-CA 125.211 1.404 . . . . 0.0 108.678 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.82 59.82 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 129.16 2.984 . . . . 0.0 112.291 -173.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -172.18 -64.86 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.745 2.418 . . . . 0.0 108.603 -162.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.53 -1.9 1.59 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.89 1.233 . . . . 0.0 113.412 -166.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -40.37 -45.91 2.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 126.086 1.754 . . . . 0.0 111.189 168.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.75 -14.97 62.64 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.2 0.937 . . . . 0.0 112.071 -170.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.48 4.37 76.48 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.449 1.023 . . . . 0.0 112.806 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.9 mtm -135.04 17.6 3.47 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.083 2.153 . . . . 0.0 111.118 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mm -60.76 -35.73 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.944 1.298 . . . . 0.0 110.863 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 45.03 14.64 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 131.447 3.899 . . . . 0.0 118.005 165.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.072 0 C-N-CA 125.308 1.432 . . . . 0.0 114.004 -178.007 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.48 -33.6 72.83 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 171.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.5 -47.08 85.53 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 122.682 0.393 . . . . 0.0 110.815 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.14 -46.12 56.7 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.404 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.66 -35.88 82.0 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.474 1.137 . . . . 0.0 112.459 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.276 86.0 mt -60.35 -92.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.635 1.974 . . . . 0.0 108.568 165.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.67 -40.4 9.11 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.281 2.232 . . . . 0.0 112.568 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.23 -28.95 74.16 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.859 1.208 . . . . 0.0 113.673 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -37.7 77.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.935 1.367 . . . . 0.0 109.906 170.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mt -68.3 -52.47 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 125.026 1.331 . . . . 0.0 108.431 179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.62 54.56 0.08 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.176 2.59 . . . . 0.0 112.357 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -175.03 -69.09 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 129.558 3.143 . . . . 0.0 108.038 -163.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.13 -4.71 9.17 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 124.792 1.187 . . . . 0.0 113.852 -167.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.1 t90 -44.04 -45.14 7.82 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 125.964 1.706 . . . . 0.0 111.097 171.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.08 -11.14 60.44 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.073 0.858 . . . . 0.0 112.067 -169.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.93 2.64 69.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.212 0.911 . . . . 0.0 112.797 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.9 mmt -130.6 8.04 4.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.697 1.999 . . . . 0.0 111.474 -172.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.428 ' C ' ' H ' ' A' ' 20' ' ' GLY . 4.2 mm -55.29 -41.12 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.323 1.449 . . . . 0.0 110.166 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.3 16.17 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 129.543 3.137 . . . . 0.0 114.683 -173.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' A' ' 18' ' ' ILE . . . . . . . . 0 CA--C 1.533 1.191 0 C-N-CA 125.782 1.658 . . . . 0.0 113.535 178.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.77 -33.13 72.49 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.171 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -63.93 -45.49 89.0 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 122.587 0.355 . . . . 0.0 110.715 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.86 -47.9 38.43 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.451 168.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.16 -41.86 98.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.587 1.193 . . . . 0.0 112.303 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.295 89.9 mt -54.88 -92.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 127.157 2.183 . . . . 0.0 109.391 167.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -44.62 -42.15 7.2 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.604 1.961 . . . . 0.0 112.622 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.35 -26.63 74.15 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.573 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -69.07 -50.45 48.26 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.266 1.533 . . . . 0.0 109.036 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mt -56.6 -42.8 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 125.262 1.425 . . . . 0.0 109.369 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -59.16 -2.25 0.26 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.0 -57.7 1.31 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.109 1.363 . . . . 0.0 110.748 159.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.87 -5.05 89.64 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.882 -0.954 . . . . 0.0 114.414 -165.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -55.61 -53.68 53.48 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 118.545 1.172 . . . . 0.0 110.881 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.01 -24.46 61.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.342 -164.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.69 10.96 28.69 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.503 1.525 . . . . 0.0 113.593 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.0 mmt -124.65 -10.95 7.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.828 1.251 . . . . 0.0 112.786 165.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.474 ' C ' ' H ' ' A' ' 20' ' ' GLY . 2.5 mm -75.41 -26.57 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.212 1.405 . . . . 0.0 110.91 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -68.84 16.46 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.63 2.372 . . . . 0.0 112.954 172.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 18' ' ' ILE . . . . . . . . 0 CA--C 1.534 1.223 0 C-N-CA 125.719 1.628 . . . . 0.0 114.305 -175.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.09 -34.31 73.29 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.121 0.569 . . . . 0.0 110.751 171.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.93 -45.63 91.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.786 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.43 -48.14 49.28 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.295 168.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.37 -34.24 77.29 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.491 1.146 . . . . 0.0 112.852 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.28 96.5 mt -60.72 -92.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.693 1.997 . . . . 0.0 108.648 164.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.45 -36.99 7.14 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.165 2.186 . . . . 0.0 113.266 -170.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.16 -26.21 72.79 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.453 1.024 . . . . 0.0 113.703 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -38.15 73.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.118 1.459 . . . . 0.0 109.46 167.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.17 -56.19 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 124.937 1.295 . . . . 0.0 110.141 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -68.86 65.38 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.83 2.852 . . . . 0.0 110.691 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.94 -51.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.349 1.86 . . . . 0.0 109.017 -163.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.88 -4.19 0.07 OUTLIER Glycine 0 C--N 1.34 0.775 0 CA-C-O 117.604 -1.665 . . . . 0.0 115.011 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.81 -36.62 72.47 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 120.162 1.981 . . . . 0.0 110.042 173.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.4 -29.82 70.17 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.489 -173.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.21 7.72 21.61 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.857 1.218 . . . . 0.0 113.845 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 48.0 mtt -130.53 6.62 4.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.26 1.424 . . . . 0.0 111.879 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 29.3 mm -72.63 -34.07 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.974 0.91 . . . . 0.0 111.21 -175.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 50.11 17.27 0.3 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.605 3.162 . . . . 0.0 116.091 167.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 C-N-CA 125.86 1.695 . . . . 0.0 113.666 -173.08 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -32.78 73.81 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 170.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -55.58 -45.68 77.33 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.695 0.798 . . . . 0.0 110.872 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.23 -24.37 55.15 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.581 -1.122 . . . . 0.0 114.04 172.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.83 -18.1 30.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.571 1.686 . . . . 0.0 112.356 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.0 mt -86.29 -93.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 126.951 2.1 . . . . 0.0 107.474 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.28 -45.5 72.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.372 1.869 . . . . 0.0 110.522 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.3 -13.61 65.25 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 119.004 0.82 . . . . 0.0 114.272 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.03 -46.28 13.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.754 1.277 . . . . 0.0 109.583 164.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -54.76 -51.94 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.058 1.743 . . . . 0.0 111.171 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -67.1 47.87 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 130.871 3.668 . . . . 0.0 113.314 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -145.17 -56.06 0.32 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.193 2.197 . . . . 0.0 109.296 -172.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.36 -4.82 0.45 Allowed Glycine 0 C--N 1.341 0.822 0 CA-C-O 118.047 -1.418 . . . . 0.0 114.112 -170.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.29 -31.51 65.71 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 119.589 1.694 . . . . 0.0 110.756 173.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.92 -30.67 68.01 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.88 0.872 . . . . 0.0 111.748 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.71 8.91 12.31 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.905 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.6 mtt -130.5 5.89 4.77 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.693 1.597 . . . . 0.0 112.001 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 25.6 mm -73.69 -31.69 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.084 0.954 . . . . 0.0 111.417 -175.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 49.75 14.48 0.12 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 130.416 3.486 . . . . 0.0 117.159 164.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.003 0 C-N-CA 125.708 1.623 . . . . 0.0 114.022 -174.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.96 -35.15 74.34 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.007 0.432 . . . . 0.0 110.472 171.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.31 -46.02 90.61 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.635 173.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.0 -46.8 49.98 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.487 168.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.08 -34.83 78.93 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.671 1.236 . . . . 0.0 112.652 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.274 97.2 mt -61.86 -92.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.811 2.044 . . . . 0.0 109.023 166.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.24 -42.75 21.02 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.333 1.853 . . . . 0.0 112.077 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.27 -23.24 76.38 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 119.573 1.079 . . . . 0.0 113.612 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.62 -49.17 50.46 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.153 1.477 . . . . 0.0 108.992 165.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.7 mt -55.23 -45.54 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 125.293 1.437 . . . . 0.0 108.932 -179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -57.11 -1.21 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.59 1.556 . . . . 0.0 114.36 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -125.29 -56.61 1.52 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.123 1.369 . . . . 0.0 110.334 158.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.11 -8.33 87.47 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.056 -0.858 . . . . 0.0 114.666 -165.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.6 t90 -53.45 -57.0 12.21 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 125.526 1.53 . . . . 0.0 110.381 175.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -70.32 3.49 2.88 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -158.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.15 2.24 59.53 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.331 -1.26 . . . . 0.0 113.644 166.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.8 mtm -125.7 -7.52 6.78 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.428 1.614 . . . . 0.0 115.344 -167.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 3.0 mp -65.9 -37.87 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.835 1.254 . . . . 0.0 110.294 -179.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.95 22.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.425 3.09 . . . . 0.0 114.161 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 C-N-CA 125.217 1.389 . . . . 0.0 114.527 -173.47 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 tt -58.08 -36.81 73.38 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.073 0.549 . . . . 0.0 110.572 168.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.24 -46.16 90.74 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.719 173.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.85 -46.5 48.88 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.957 -0.913 . . . . 0.0 112.074 169.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.01 -25.27 67.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.773 1.286 . . . . 0.0 113.039 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.12 -92.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 126.662 1.985 . . . . 0.0 107.972 167.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.81 -42.06 16.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.542 2.337 . . . . 0.0 112.615 -171.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.65 -14.4 77.86 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.409 1.004 . . . . 0.0 113.943 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -40.5 23.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.77 1.285 . . . . 0.0 109.462 163.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.58 -53.05 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.449 1.5 . . . . 0.0 111.293 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.3 64.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.824 2.85 . . . . 0.0 111.949 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -160.54 -54.53 0.05 Allowed 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 126.817 2.047 . . . . 0.0 110.02 -167.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.46 10.58 0.06 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.593 -1.115 . . . . 0.0 113.391 -171.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -20.29 46.55 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.455 1.627 . . . . 0.0 111.753 172.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -54.36 -31.69 55.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.863 1.265 . . . . 0.0 111.368 173.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.57 -11.26 47.72 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.51 -0.744 . . . . 0.0 113.507 173.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.0 mmm -109.54 -3.63 16.81 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.46 1.904 . . . . 0.0 112.243 171.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt -84.99 -37.85 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.296 1.438 . . . . 0.0 108.637 167.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -69.06 71.14 0.23 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.421 1.489 . . . . 0.0 110.871 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 C-N-CA 125.478 1.513 . . . . 0.0 110.625 178.001 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.3 p . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tt -58.55 -36.32 73.71 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.144 0.497 . . . . 0.0 110.517 169.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.49 -44.44 94.33 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.628 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.39 -48.16 42.02 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.265 0.936 . . . . 0.0 111.704 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.58 75.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.786 1.293 . . . . 0.0 112.604 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.263 98.1 mt -63.95 -92.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.704 2.002 . . . . 0.0 108.75 166.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.41 -42.79 15.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.93 2.092 . . . . 0.0 112.273 -170.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.1 -23.04 71.14 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 119.44 1.018 . . . . 0.0 113.59 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -46.71 50.24 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.818 1.309 . . . . 0.0 109.415 167.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.6 mt -57.84 -43.75 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.537 1.535 . . . . 0.0 108.553 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -57.19 -2.75 0.11 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.253 1.421 . . . . 0.0 114.342 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.1 -54.66 1.49 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.088 1.355 . . . . 0.0 110.634 158.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.93 -8.17 87.97 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.029 -0.873 . . . . 0.0 114.513 -166.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.464 ' HB2' HG23 ' A' ' 10' ' ' ILE . 18.4 t90 -56.01 -47.51 77.64 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.511 1.155 . . . . 0.0 111.203 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.28 -18.87 61.77 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.65 0.594 . . . . 0.0 112.235 -161.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.63 -3.94 90.3 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.206 -0.774 . . . . 0.0 113.085 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 89.0 mmm -129.0 9.28 5.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.375 1.87 . . . . 0.0 111.84 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm . . . . . 0 N--CA 1.466 0.341 0 C-N-CA 124.831 1.252 . . . . 0.0 110.145 -177.899 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.45 -34.18 73.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.206 0.527 . . . . 0.0 110.468 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -63.3 -44.22 95.63 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.778 173.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.45 -48.67 41.27 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.013 -0.882 . . . . 0.0 111.553 167.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.13 84.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.798 1.299 . . . . 0.0 112.529 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.285 96.8 mt -58.42 -92.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.991 2.116 . . . . 0.0 109.152 166.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.86 -37.05 8.18 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.819 2.048 . . . . 0.0 113.168 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.01 -18.86 79.77 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.573 1.082 . . . . 0.0 113.967 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.87 -48.1 19.33 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.983 1.392 . . . . 0.0 108.796 161.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.8 mt -58.85 -43.61 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.322 1.449 . . . . 0.0 109.278 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.74 -0.95 0.33 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 120.236 1.38 . . . . 0.0 114.4 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -122.62 -56.73 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.912 1.285 . . . . 0.0 110.45 159.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.79 -8.31 87.8 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.899 -0.945 . . . . 0.0 114.801 -166.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.46 ' HB2' HG23 ' A' ' 10' ' ' ILE . 18.6 t90 -55.59 -48.8 74.24 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.83 1.252 . . . . 0.0 111.018 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -75.42 -15.79 60.41 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.746 -159.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.3 -2.03 83.39 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.139 -0.812 . . . . 0.0 112.959 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 92.0 mmm -125.81 5.26 7.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.838 1.655 . . . . 0.0 111.973 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mm . . . . . 0 CA--C 1.532 0.286 0 C-N-CA 124.696 1.199 . . . . 0.0 110.115 -178.847 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 tt -58.42 -36.55 73.78 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.043 0.537 . . . . 0.0 110.914 170.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.37 -41.07 89.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.814 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.46 -48.37 65.17 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 119.101 -0.833 . . . . 0.0 111.406 165.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.37 -32.05 73.37 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.586 1.193 . . . . 0.0 112.473 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.273 95.9 mt -60.63 -92.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.774 2.03 . . . . 0.0 108.279 162.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -51.14 -39.28 55.91 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.231 1.813 . . . . 0.0 113.304 -165.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.92 -17.49 79.38 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.339 0.971 . . . . 0.0 113.549 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.17 -50.59 9.41 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.44 1.12 . . . . 0.0 108.737 162.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mt -56.63 -40.33 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 125.694 1.598 . . . . 0.0 110.307 -173.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.01 -3.03 0.49 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.799 1.181 . . . . 0.0 113.96 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -123.97 -60.52 1.43 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.332 1.453 . . . . 0.0 110.385 159.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.62 84.36 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.535 1.064 . . . . 0.0 114.582 -164.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 t90 -53.31 -41.79 66.03 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.379 1.09 . . . . 0.0 111.543 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.04 -36.63 84.21 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.749 0.656 . . . . 0.0 111.269 -164.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.17 -1.11 62.86 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.798 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 mmt -119.48 3.33 11.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.08 1.752 . . . . 0.0 111.706 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm . . . . . 0 C--N 1.342 0.281 0 C-N-CA 123.782 0.833 . . . . 0.0 109.264 177.928 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.5 p . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -32.72 72.33 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 170.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -60.83 -47.01 88.29 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 122.969 0.508 . . . . 0.0 110.774 172.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.37 -48.68 47.47 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.873 0.749 . . . . 0.0 111.565 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.02 -20.27 65.79 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.5 mt -86.12 -93.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 126.4 1.88 . . . . 0.0 108.004 168.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.54 79.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.432 2.293 . . . . 0.0 112.614 -169.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.79 -38.73 66.15 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 119.13 0.877 . . . . 0.0 111.845 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -44.65 93.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.876 0.87 . . . . 0.0 110.419 167.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -64.01 -53.41 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 124.681 1.192 . . . . 0.0 108.754 -176.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -70.64 63.88 0.28 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.964 1.706 . . . . 0.0 111.626 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.9 -61.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 129.249 3.02 . . . . 0.0 108.646 -163.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.26 -4.27 4.09 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.059 1.314 . . . . 0.0 113.573 -168.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.525 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.3 t90 -46.38 -40.11 11.46 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 126.168 1.787 . . . . 0.0 110.807 170.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.07 -19.47 65.66 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.783 0.677 . . . . 0.0 112.106 -172.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.22 2.02 83.13 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.063 0.84 . . . . 0.0 112.959 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.6 mmt -128.2 6.54 5.9 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.083 2.153 . . . . 0.0 111.464 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 mm . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.835 1.254 . . . . 0.0 109.85 177.473 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.4 p . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.93 -34.16 72.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.844 0.458 . . . . 0.0 110.321 170.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -62.83 -44.39 96.28 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 122.977 0.511 . . . . 0.0 110.672 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.52 -47.76 50.77 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.949 -0.917 . . . . 0.0 111.479 168.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.99 91.87 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.542 1.171 . . . . 0.0 112.434 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.287 96.6 mt -56.55 -92.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.884 2.073 . . . . 0.0 109.017 165.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.0 -37.26 3.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 127.403 2.281 . . . . 0.0 113.131 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.06 -28.37 73.0 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.683 1.129 . . . . 0.0 113.601 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.66 -39.04 67.45 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.899 1.35 . . . . 0.0 109.733 168.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -68.09 -49.7 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -175.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.39 55.91 0.82 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.984 1.265 . . . . 0.0 110.634 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.63 -67.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.666 3.986 . . . . 0.0 107.234 -161.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.54 -5.38 16.4 Favored Glycine 0 C--N 1.345 1.067 0 C-N-CA 124.65 1.119 . . . . 0.0 114.284 -166.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.521 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.0 t90 -48.02 -45.45 31.9 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.717 1.607 . . . . 0.0 109.854 172.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.84 -23.96 65.22 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 124.525 1.141 . . . . 0.0 111.441 -166.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.09 -10.05 80.83 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.583 -1.121 . . . . 0.0 113.268 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.4 mmm -122.07 12.61 10.39 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.503 1.521 . . . . 0.0 111.942 -173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 mm . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.259 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.8 p . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.05 -32.56 72.19 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 170.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -59.33 -46.67 87.96 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.151 0.58 . . . . 0.0 110.889 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.93 -44.13 55.67 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.088 -0.84 . . . . 0.0 111.99 170.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.73 -32.37 73.63 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.742 1.271 . . . . 0.0 112.718 176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.0 mt -70.36 -92.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.819 2.047 . . . . 0.0 108.571 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.49 -43.26 55.55 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.506 1.922 . . . . 0.0 111.567 -172.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.78 -21.78 73.3 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.583 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -71.75 -51.14 24.31 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.134 1.467 . . . . 0.0 109.079 165.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.417 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.5 mt -55.07 -44.01 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 125.733 1.613 . . . . 0.0 109.019 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.49 -3.98 0.13 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.433 1.493 . . . . 0.0 114.278 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.53 -56.25 1.4 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.171 1.389 . . . . 0.0 110.849 158.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.86 -7.28 88.4 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.398 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.417 ' HB2' HG23 ' A' ' 10' ' ' ILE . 20.5 t90 -53.56 -51.44 62.91 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 124.668 1.187 . . . . 0.0 110.852 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.81 -20.08 61.9 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 123.918 0.761 . . . . 0.0 111.638 -163.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.43 -5.94 89.55 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.409 -1.217 . . . . 0.0 113.209 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.3 mmm -128.1 16.3 6.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.425 1.89 . . . . 0.0 111.838 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mm . . . . . 0 CA--C 1.54 0.575 0 C-N-CA 123.894 0.878 . . . . 0.0 110.802 -179.383 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.87 -34.78 73.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.711 0.404 . . . . 0.0 110.119 170.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.82 -45.64 92.95 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.65 0.38 . . . . 0.0 110.689 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.98 -48.79 37.67 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.174 0.892 . . . . 0.0 111.609 168.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.78 76.33 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.233 1.016 . . . . 0.0 112.784 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.257 96.5 mt -65.27 -92.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.59 1.956 . . . . 0.0 108.555 167.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.54 -39.36 48.95 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.527 1.931 . . . . 0.0 112.318 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.32 -22.86 77.68 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.574 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -71.75 -48.25 48.1 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.16 1.48 . . . . 0.0 109.076 164.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.8 mt -59.19 -45.36 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 C-N-CA 125.213 1.405 . . . . 0.0 108.822 -173.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -61.89 4.72 0.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.106 1.321 . . . . 0.0 114.252 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.86 -54.85 1.4 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.721 1.608 . . . . 0.0 109.872 158.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.82 -10.74 84.73 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.967 -0.907 . . . . 0.0 114.496 -167.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.484 ' HB2' HG23 ' A' ' 10' ' ' ILE . 19.3 t90 -56.86 -53.53 56.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.169 1.388 . . . . 0.0 110.429 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -69.83 -29.61 66.92 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.902 0.751 . . . . 0.0 110.745 -161.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.31 4.84 46.93 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.242 -1.31 . . . . 0.0 113.832 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 70.2 mtp -132.9 11.83 4.32 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.317 1.447 . . . . 0.0 112.204 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 mm . . . . . 0 CA--C 1.538 0.501 0 CA-C-N 119.219 0.918 . . . . 0.0 110.474 -179.229 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -30.85 71.89 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 171.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -56.7 -43.76 80.84 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.436 0.695 . . . . 0.0 110.676 170.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.34 -21.12 46.97 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.875 1.226 . . . . 0.0 114.313 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.25 -19.96 20.24 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.634 1.717 . . . . 0.0 112.322 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.1 mt -86.1 -93.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.009 2.124 . . . . 0.0 107.126 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.74 -43.14 80.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.117 1.767 . . . . 0.0 110.397 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.29 -21.17 71.97 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.682 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -76.51 -52.42 9.81 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.781 1.291 . . . . 0.0 109.427 165.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.7 mt -54.87 -41.69 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 126.048 1.739 . . . . 0.0 109.382 -173.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -59.1 -2.65 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.15 -56.61 1.43 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.54 1.536 . . . . 0.0 110.504 158.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.79 -2.67 88.62 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.283 0.944 . . . . 0.0 114.609 -166.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.477 ' HB2' HG23 ' A' ' 10' ' ' ILE . 18.0 t90 -57.08 -49.02 77.15 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 118.471 1.135 . . . . 0.0 110.947 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.26 -33.72 75.93 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 123.686 0.616 . . . . 0.0 110.937 -163.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.86 4.48 45.14 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.665 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -133.13 12.99 4.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.216 1.806 . . . . 0.0 111.463 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm . . . . . 0 CA--C 1.538 0.483 0 O-C-N 121.344 -0.848 . . . . 0.0 110.427 178.904 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -32.76 72.01 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.13 -46.89 82.16 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.877 -0.515 . . . . 0.0 110.705 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.46 -49.43 39.13 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.983 0.801 . . . . 0.0 111.237 169.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.95 -35.05 78.86 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 117.995 0.898 . . . . 0.0 112.581 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.267 74.7 mt -63.63 -92.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 126.78 2.032 . . . . 0.0 108.575 167.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.45 -41.45 20.5 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.854 2.062 . . . . 0.0 112.091 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.8 -25.39 71.79 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 119.832 1.196 . . . . 0.0 113.916 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -41.24 61.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.898 1.349 . . . . 0.0 109.849 169.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -64.94 -48.05 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 124.959 1.304 . . . . 0.0 108.03 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.7 42.65 0.06 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 127.044 2.137 . . . . 0.0 112.633 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -160.7 -65.46 0.06 Allowed 'General case' 0 N--CA 1.452 -0.358 1 C-N-CA 132.664 4.386 . . . . 0.0 106.805 -176.712 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.91 -7.25 25.56 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 118.931 -0.927 . . . . 0.0 114.201 -165.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.525 ' HB2' HG23 ' A' ' 10' ' ' ILE . 19.6 t90 -47.82 -43.87 28.35 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.336 1.454 . . . . 0.0 110.553 174.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.03 -12.34 60.59 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.021 0.826 . . . . 0.0 111.987 -166.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.38 -0.65 72.99 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.999 0.809 . . . . 0.0 112.867 168.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 91.8 mmm -129.59 8.86 5.43 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.095 2.158 . . . . 0.0 111.922 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mm . . . . . 0 N--CA 1.465 0.303 0 C-N-CA 125.203 1.401 . . . . 0.0 110.289 -177.205 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.29 -33.65 73.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.785 0.326 . . . . 0.0 110.328 172.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -63.61 -44.42 94.01 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.731 0.413 . . . . 0.0 110.933 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.61 -49.06 47.98 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.207 168.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.77 83.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.06 0.93 . . . . 0.0 112.521 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.293 90.1 mt -57.11 -92.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.957 2.103 . . . . 0.0 108.953 164.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.05 -38.26 7.72 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.773 2.029 . . . . 0.0 113.064 -170.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.5 -25.06 76.28 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.829 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.81 -36.86 62.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.033 1.416 . . . . 0.0 110.004 168.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -70.02 -54.59 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 125.148 1.379 . . . . 0.0 108.537 -174.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.4 69.54 0.39 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.487 1.915 . . . . 0.0 110.906 -172.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.34 -59.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 127.694 2.398 . . . . 0.0 108.689 -160.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.09 4.81 0.24 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.123 1.344 . . . . 0.0 112.863 -164.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.459 ' HB2' HG23 ' A' ' 10' ' ' ILE . 10.5 t90 -43.15 -38.95 2.64 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 126.391 1.876 . . . . 0.0 111.481 165.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.77 -34.05 77.02 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.916 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.5 -9.4 73.58 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.577 1.084 . . . . 0.0 113.049 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.2 mmm -102.18 3.84 38.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.428 1.491 . . . . 0.0 111.232 169.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 p . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.38 -32.86 71.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.637 0.375 . . . . 0.0 110.088 170.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -61.81 -47.2 86.2 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.048 0.539 . . . . 0.0 110.841 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.88 -49.94 33.84 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.059 0.838 . . . . 0.0 111.342 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.42 -21.49 66.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.187 0.993 . . . . 0.0 113.542 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.25 77.4 mt -82.24 -92.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 126.941 2.096 . . . . 0.0 107.708 169.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.66 -39.56 17.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.3 2.24 . . . . 0.0 112.933 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.01 -14.42 82.24 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.993 0.806 . . . . 0.0 113.715 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -45.55 13.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.462 1.131 . . . . 0.0 108.551 163.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.427 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.8 mt -58.29 -42.91 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 C-N-CA 125.369 1.468 . . . . 0.0 109.2 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.14 0.11 0.19 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.29 -55.29 1.45 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.306 1.442 . . . . 0.0 110.545 159.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.41 -9.05 87.07 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.12 -0.822 . . . . 0.0 114.535 -166.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.427 ' HB2' HG23 ' A' ' 10' ' ' ILE . 22.5 t90 -59.87 -56.0 27.15 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.905 1.282 . . . . 0.0 111.004 177.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.73 -25.64 63.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.887 -158.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.44 -1.43 76.03 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.555 -1.136 . . . . 0.0 113.698 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.3 mtm -135.95 22.49 3.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.061 1.745 . . . . 0.0 111.476 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 124.084 0.954 . . . . 0.0 110.709 178.651 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -32.43 73.01 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 171.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.78 -45.75 91.22 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 121.936 -0.478 . . . . 0.0 110.701 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.34 -48.92 39.91 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.189 0.9 . . . . 0.0 111.53 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.21 -32.55 73.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.577 1.188 . . . . 0.0 112.67 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.262 68.5 mt -68.75 -92.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.869 2.068 . . . . 0.0 108.585 169.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.51 -38.49 20.37 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 127.082 2.153 . . . . 0.0 113.117 -172.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.26 79.84 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.065 0.84 . . . . 0.0 113.818 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -78.34 -50.02 12.55 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.79 1.295 . . . . 0.0 108.639 161.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.88 -41.82 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 125.284 1.434 . . . . 0.0 110.115 -173.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.17 -1.63 0.34 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.207 1.367 . . . . 0.0 114.459 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.13 -58.04 1.38 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.002 1.321 . . . . 0.0 110.575 159.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.88 -6.87 87.43 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.392 -165.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -54.14 -52.78 60.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.616 1.167 . . . . 0.0 111.01 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.36 -22.65 62.76 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.843 0.714 . . . . 0.0 111.495 -162.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.7 -0.59 89.51 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.36 -1.244 . . . . 0.0 113.446 173.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.1 mtt -137.96 23.05 2.84 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.619 1.568 . . . . 0.0 111.31 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mm . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 124.503 1.121 . . . . 0.0 110.929 179.244 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.21 -37.77 75.47 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 110.267 169.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.83 -45.17 90.65 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.219 0.533 . . . . 0.0 110.529 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.82 -36.09 59.33 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.703 1.144 . . . . 0.0 113.067 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.21 -27.5 53.5 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.377 1.589 . . . . 0.0 112.579 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -85.99 -93.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.398 1.879 . . . . 0.0 108.461 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.13 -38.22 76.09 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.034 1.734 . . . . 0.0 110.631 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.02 -22.52 75.93 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.862 -0.965 . . . . 0.0 113.463 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.81 -48.96 33.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.009 1.405 . . . . 0.0 109.165 165.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -58.91 -44.63 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 125.314 1.446 . . . . 0.0 108.729 -173.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -64.72 9.47 0.09 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 120.317 1.417 . . . . 0.0 114.099 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.13 -56.4 1.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.908 2.083 . . . . 0.0 109.364 158.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.1 -9.68 84.87 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.254 -0.748 . . . . 0.0 114.67 -166.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.546 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.2 t90 -58.01 -45.89 86.15 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 125.213 1.405 . . . . 0.0 110.988 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.44 -32.8 74.39 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 123.842 0.714 . . . . 0.0 111.035 -163.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.71 1.69 51.87 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.626 -1.097 . . . . 0.0 113.687 174.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.42 15.16 5.01 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.401 1.88 . . . . 0.0 111.212 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 mm . . . . . 0 CA--C 1.537 0.447 0 O-C-N 121.326 -0.859 . . . . 0.0 109.486 175.91 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.83 -32.6 71.98 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 170.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -62.77 -47.28 84.17 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 122.035 -0.416 . . . . 0.0 110.81 173.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.16 -48.9 38.67 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 123.98 0.8 . . . . 0.0 111.254 169.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.35 77.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.924 0.862 . . . . 0.0 112.764 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.268 70.8 mt -62.55 -92.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.82 2.048 . . . . 0.0 108.492 166.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.81 -40.51 29.45 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.707 2.003 . . . . 0.0 112.48 -169.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.14 77.19 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 119.737 1.153 . . . . 0.0 113.377 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -37.61 83.09 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.711 1.256 . . . . 0.0 110.107 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mt -69.02 -54.4 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 C-N-CA 125.211 1.404 . . . . 0.0 108.678 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.82 59.82 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 129.16 2.984 . . . . 0.0 112.291 -173.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -172.18 -64.86 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.745 2.418 . . . . 0.0 108.603 -162.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.53 -1.9 1.59 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.89 1.233 . . . . 0.0 113.412 -166.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -40.37 -45.91 2.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 126.086 1.754 . . . . 0.0 111.189 168.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.75 -14.97 62.64 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.2 0.937 . . . . 0.0 112.071 -170.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.48 4.37 76.48 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.449 1.023 . . . . 0.0 112.806 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.9 mtm -135.04 17.6 3.47 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.083 2.153 . . . . 0.0 111.118 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mm . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 124.944 1.298 . . . . 0.0 110.863 -178.583 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.48 -33.6 72.83 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 171.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.5 -47.08 85.53 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 122.682 0.393 . . . . 0.0 110.815 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.14 -46.12 56.7 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.404 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.66 -35.88 82.0 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.474 1.137 . . . . 0.0 112.459 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.276 86.0 mt -60.35 -92.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.635 1.974 . . . . 0.0 108.568 165.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.67 -40.4 9.11 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.281 2.232 . . . . 0.0 112.568 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.23 -28.95 74.16 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.859 1.208 . . . . 0.0 113.673 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -37.7 77.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.935 1.367 . . . . 0.0 109.906 170.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.428 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.7 mt -68.3 -52.47 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 125.026 1.331 . . . . 0.0 108.431 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.62 54.56 0.08 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.176 2.59 . . . . 0.0 112.357 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -175.03 -69.09 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 129.558 3.143 . . . . 0.0 108.038 -163.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.13 -4.71 9.17 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 124.792 1.187 . . . . 0.0 113.852 -167.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.428 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.1 t90 -44.04 -45.14 7.82 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 125.964 1.706 . . . . 0.0 111.097 171.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.08 -11.14 60.44 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.073 0.858 . . . . 0.0 112.067 -169.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.93 2.64 69.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.212 0.911 . . . . 0.0 112.797 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.9 mmt -130.6 8.04 4.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.697 1.999 . . . . 0.0 111.474 -172.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mm . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 125.323 1.449 . . . . 0.0 110.166 -179.437 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.77 -33.13 72.49 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.171 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -63.93 -45.49 89.0 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 122.587 0.355 . . . . 0.0 110.715 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.86 -47.9 38.43 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.451 168.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.16 -41.86 98.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.587 1.193 . . . . 0.0 112.303 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.295 89.9 mt -54.88 -92.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 127.157 2.183 . . . . 0.0 109.391 167.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -44.62 -42.15 7.2 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.604 1.961 . . . . 0.0 112.622 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.35 -26.63 74.15 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.573 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -69.07 -50.45 48.26 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.266 1.533 . . . . 0.0 109.036 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mt -56.6 -42.8 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 125.262 1.425 . . . . 0.0 109.369 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -59.16 -2.25 0.26 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.0 -57.7 1.31 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.109 1.363 . . . . 0.0 110.748 159.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.87 -5.05 89.64 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.882 -0.954 . . . . 0.0 114.414 -165.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -55.61 -53.68 53.48 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 118.545 1.172 . . . . 0.0 110.881 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.01 -24.46 61.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.342 -164.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.69 10.96 28.69 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.503 1.525 . . . . 0.0 113.593 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.0 mmt -124.65 -10.95 7.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.828 1.251 . . . . 0.0 112.786 165.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mm . . . . . 0 CA--C 1.532 0.256 0 C-N-CA 125.212 1.405 . . . . 0.0 110.91 179.353 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.09 -34.31 73.29 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.121 0.569 . . . . 0.0 110.751 171.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.93 -45.63 91.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.786 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.43 -48.14 49.28 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.295 168.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.37 -34.24 77.29 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.491 1.146 . . . . 0.0 112.852 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.28 96.5 mt -60.72 -92.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.693 1.997 . . . . 0.0 108.648 164.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.45 -36.99 7.14 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.165 2.186 . . . . 0.0 113.266 -170.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.16 -26.21 72.79 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.453 1.024 . . . . 0.0 113.703 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -38.15 73.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.118 1.459 . . . . 0.0 109.46 167.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.17 -56.19 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 124.937 1.295 . . . . 0.0 110.141 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -68.86 65.38 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.83 2.852 . . . . 0.0 110.691 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.94 -51.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.349 1.86 . . . . 0.0 109.017 -163.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.88 -4.19 0.07 OUTLIER Glycine 0 C--N 1.34 0.775 0 CA-C-O 117.604 -1.665 . . . . 0.0 115.011 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.548 ' NE1' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -57.81 -36.62 72.47 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 120.162 1.981 . . . . 0.0 110.042 173.18 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.4 -29.82 70.17 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.489 -173.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.21 7.72 21.61 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.857 1.218 . . . . 0.0 113.845 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 48.0 mtt -130.53 6.62 4.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.26 1.424 . . . . 0.0 111.879 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.548 HD11 ' NE1' ' A' ' 14' ' ' TRP . 29.3 mm . . . . . 0 CA--C 1.533 0.313 0 C-N-CA 123.974 0.91 . . . . 0.0 111.21 -175.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -32.78 73.81 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 170.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -55.58 -45.68 77.33 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.695 0.798 . . . . 0.0 110.872 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.23 -24.37 55.15 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.581 -1.122 . . . . 0.0 114.04 172.638 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.83 -18.1 30.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.571 1.686 . . . . 0.0 112.356 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.0 mt -86.29 -93.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 126.951 2.1 . . . . 0.0 107.474 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.28 -45.5 72.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.372 1.869 . . . . 0.0 110.522 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.3 -13.61 65.25 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 119.004 0.82 . . . . 0.0 114.272 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.03 -46.28 13.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.754 1.277 . . . . 0.0 109.583 164.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -54.76 -51.94 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.058 1.743 . . . . 0.0 111.171 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -67.1 47.87 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 130.871 3.668 . . . . 0.0 113.314 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -145.17 -56.06 0.32 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.193 2.197 . . . . 0.0 109.296 -172.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.36 -4.82 0.45 Allowed Glycine 0 C--N 1.341 0.822 0 CA-C-O 118.047 -1.418 . . . . 0.0 114.112 -170.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.547 ' NE1' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -57.29 -31.51 65.71 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 119.589 1.694 . . . . 0.0 110.756 173.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.92 -30.67 68.01 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.88 0.872 . . . . 0.0 111.748 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.71 8.91 12.31 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.905 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.6 mtt -130.5 5.89 4.77 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.693 1.597 . . . . 0.0 112.001 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.547 HD11 ' NE1' ' A' ' 14' ' ' TRP . 25.6 mm . . . . . 0 CA--C 1.533 0.307 0 C-N-CA 124.084 0.954 . . . . 0.0 111.417 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.96 -35.15 74.34 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.007 0.432 . . . . 0.0 110.472 171.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.31 -46.02 90.61 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.635 173.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.0 -46.8 49.98 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.487 168.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.08 -34.83 78.93 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.671 1.236 . . . . 0.0 112.652 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.274 97.2 mt -61.86 -92.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.811 2.044 . . . . 0.0 109.023 166.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.24 -42.75 21.02 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.333 1.853 . . . . 0.0 112.077 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.27 -23.24 76.38 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 119.573 1.079 . . . . 0.0 113.612 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.62 -49.17 50.46 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.153 1.477 . . . . 0.0 108.992 165.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.7 mt -55.23 -45.54 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 125.293 1.437 . . . . 0.0 108.932 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -57.11 -1.21 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.59 1.556 . . . . 0.0 114.36 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -125.29 -56.61 1.52 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.123 1.369 . . . . 0.0 110.334 158.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.11 -8.33 87.47 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.056 -0.858 . . . . 0.0 114.666 -165.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.727 ' CD1' HD11 ' A' ' 18' ' ' ILE . 21.6 t90 -53.45 -57.0 12.21 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 125.526 1.53 . . . . 0.0 110.381 175.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.599 ' HA ' HD13 ' A' ' 18' ' ' ILE . 47.6 mt-10 -70.32 3.49 2.88 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -158.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.15 2.24 59.53 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.331 -1.26 . . . . 0.0 113.644 166.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.8 mtm -125.7 -7.52 6.78 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.428 1.614 . . . . 0.0 115.344 -167.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.727 HD11 ' CD1' ' A' ' 14' ' ' TRP . 3.0 mp . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 124.835 1.254 . . . . 0.0 110.294 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 tt -58.08 -36.81 73.38 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.073 0.549 . . . . 0.0 110.572 168.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.24 -46.16 90.74 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.719 173.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.85 -46.5 48.88 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.957 -0.913 . . . . 0.0 112.074 169.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.01 -25.27 67.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.773 1.286 . . . . 0.0 113.039 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.12 -92.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 126.662 1.985 . . . . 0.0 107.972 167.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.81 -42.06 16.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.542 2.337 . . . . 0.0 112.615 -171.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.65 -14.4 77.86 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.409 1.004 . . . . 0.0 113.943 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -40.5 23.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.77 1.285 . . . . 0.0 109.462 163.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.58 -53.05 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.449 1.5 . . . . 0.0 111.293 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.3 64.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.824 2.85 . . . . 0.0 111.949 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -160.54 -54.53 0.05 Allowed 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 126.817 2.047 . . . . 0.0 110.02 -167.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.46 10.58 0.06 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.593 -1.115 . . . . 0.0 113.391 -171.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -20.29 46.55 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.455 1.627 . . . . 0.0 111.753 172.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -54.36 -31.69 55.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.863 1.265 . . . . 0.0 111.368 173.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.57 -11.26 47.72 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.51 -0.744 . . . . 0.0 113.507 173.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.0 mmm -109.54 -3.63 16.81 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.46 1.904 . . . . 0.0 112.243 171.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 CA--C 1.534 0.336 0 C-N-CA 125.296 1.438 . . . . 0.0 108.637 167.063 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.3 p . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tt -58.55 -36.32 73.71 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.144 0.497 . . . . 0.0 110.517 169.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.49 -44.44 94.33 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.628 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.39 -48.16 42.02 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.265 0.936 . . . . 0.0 111.704 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.58 75.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.786 1.293 . . . . 0.0 112.604 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.263 98.1 mt -63.95 -92.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.704 2.002 . . . . 0.0 108.75 166.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.41 -42.79 15.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.93 2.092 . . . . 0.0 112.273 -170.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.1 -23.04 71.14 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 119.44 1.018 . . . . 0.0 113.59 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -46.71 50.24 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.818 1.309 . . . . 0.0 109.415 167.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.6 mt -57.84 -43.75 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.537 1.535 . . . . 0.0 108.553 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -57.19 -2.75 0.11 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.253 1.421 . . . . 0.0 114.342 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.1 -54.66 1.49 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.088 1.355 . . . . 0.0 110.634 158.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.93 -8.17 87.97 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.029 -0.873 . . . . 0.0 114.513 -166.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.464 ' HB2' HG23 ' A' ' 10' ' ' ILE . 18.4 t90 -56.01 -47.51 77.64 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.511 1.155 . . . . 0.0 111.203 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.28 -18.87 61.77 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.65 0.594 . . . . 0.0 112.235 -161.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.63 -3.94 90.3 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.206 -0.774 . . . . 0.0 113.085 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 89.0 mmm -129.0 9.28 5.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.375 1.87 . . . . 0.0 111.84 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -55.33 -45.64 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.831 1.252 . . . . 0.0 110.145 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.72 19.06 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.458 2.703 . . . . 0.0 113.551 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 125.673 1.606 . . . . 0.0 114.486 -172.2 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.45 -34.18 73.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.206 0.527 . . . . 0.0 110.468 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -63.3 -44.22 95.63 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.778 173.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.45 -48.67 41.27 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.013 -0.882 . . . . 0.0 111.553 167.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.13 84.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.798 1.299 . . . . 0.0 112.529 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.285 96.8 mt -58.42 -92.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.991 2.116 . . . . 0.0 109.152 166.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.86 -37.05 8.18 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.819 2.048 . . . . 0.0 113.168 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.01 -18.86 79.77 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.573 1.082 . . . . 0.0 113.967 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.87 -48.1 19.33 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.983 1.392 . . . . 0.0 108.796 161.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.8 mt -58.85 -43.61 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.322 1.449 . . . . 0.0 109.278 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.74 -0.95 0.33 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 120.236 1.38 . . . . 0.0 114.4 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -122.62 -56.73 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.912 1.285 . . . . 0.0 110.45 159.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.79 -8.31 87.8 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.899 -0.945 . . . . 0.0 114.801 -166.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.46 ' HB2' HG23 ' A' ' 10' ' ' ILE . 18.6 t90 -55.59 -48.8 74.24 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.83 1.252 . . . . 0.0 111.018 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -75.42 -15.79 60.41 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.746 -159.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.3 -2.03 83.39 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.139 -0.812 . . . . 0.0 112.959 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 92.0 mmm -125.81 5.26 7.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.838 1.655 . . . . 0.0 111.973 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mm -55.98 -45.09 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.696 1.199 . . . . 0.0 110.115 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.78 18.98 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.757 2.823 . . . . 0.0 113.972 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.141 0 C-N-CA 125.166 1.365 . . . . 0.0 114.48 -173.215 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 tt -58.42 -36.55 73.78 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.043 0.537 . . . . 0.0 110.914 170.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.37 -41.07 89.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.814 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.46 -48.37 65.17 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 119.101 -0.833 . . . . 0.0 111.406 165.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.37 -32.05 73.37 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.586 1.193 . . . . 0.0 112.473 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.273 95.9 mt -60.63 -92.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.774 2.03 . . . . 0.0 108.279 162.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -51.14 -39.28 55.91 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.231 1.813 . . . . 0.0 113.304 -165.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.92 -17.49 79.38 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.339 0.971 . . . . 0.0 113.549 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.17 -50.59 9.41 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.44 1.12 . . . . 0.0 108.737 162.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mt -56.63 -40.33 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 125.694 1.598 . . . . 0.0 110.307 -173.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.01 -3.03 0.49 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.799 1.181 . . . . 0.0 113.96 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -123.97 -60.52 1.43 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.332 1.453 . . . . 0.0 110.385 159.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.62 84.36 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.535 1.064 . . . . 0.0 114.582 -164.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 t90 -53.31 -41.79 66.03 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.379 1.09 . . . . 0.0 111.543 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.04 -36.63 84.21 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.749 0.656 . . . . 0.0 111.269 -164.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.17 -1.11 62.86 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.798 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 mmt -119.48 3.33 11.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.08 1.752 . . . . 0.0 111.706 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -57.87 -48.72 83.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 123.782 0.833 . . . . 0.0 109.264 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.51 19.35 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.334 2.654 . . . . 0.0 113.407 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.152 0 C-N-CA 125.265 1.412 . . . . 0.0 114.711 -170.137 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.5 p . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -32.72 72.33 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 170.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -60.83 -47.01 88.29 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 122.969 0.508 . . . . 0.0 110.774 172.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.37 -48.68 47.47 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.873 0.749 . . . . 0.0 111.565 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.02 -20.27 65.79 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.5 mt -86.12 -93.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 126.4 1.88 . . . . 0.0 108.004 168.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.54 79.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.432 2.293 . . . . 0.0 112.614 -169.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.79 -38.73 66.15 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 119.13 0.877 . . . . 0.0 111.845 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -44.65 93.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.876 0.87 . . . . 0.0 110.419 167.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -64.01 -53.41 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 124.681 1.192 . . . . 0.0 108.754 -176.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -70.64 63.88 0.28 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.964 1.706 . . . . 0.0 111.626 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.9 -61.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 129.249 3.02 . . . . 0.0 108.646 -163.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.26 -4.27 4.09 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.059 1.314 . . . . 0.0 113.573 -168.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.525 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.3 t90 -46.38 -40.11 11.46 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 126.168 1.787 . . . . 0.0 110.807 170.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.07 -19.47 65.66 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.783 0.677 . . . . 0.0 112.106 -172.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.22 2.02 83.13 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.063 0.84 . . . . 0.0 112.959 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.6 mmt -128.2 6.54 5.9 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.083 2.153 . . . . 0.0 111.464 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 mm -55.95 -40.24 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.835 1.254 . . . . 0.0 109.85 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.83 17.87 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.77 3.228 . . . . 0.0 114.435 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.108 0 C-N-CA 125.522 1.534 . . . . 0.0 114.153 -175.767 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.4 p . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.93 -34.16 72.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.844 0.458 . . . . 0.0 110.321 170.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -62.83 -44.39 96.28 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 122.977 0.511 . . . . 0.0 110.672 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.52 -47.76 50.77 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.949 -0.917 . . . . 0.0 111.479 168.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.99 91.87 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.542 1.171 . . . . 0.0 112.434 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.287 96.6 mt -56.55 -92.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.884 2.073 . . . . 0.0 109.017 165.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.0 -37.26 3.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 127.403 2.281 . . . . 0.0 113.131 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.06 -28.37 73.0 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.683 1.129 . . . . 0.0 113.601 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.66 -39.04 67.45 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.899 1.35 . . . . 0.0 109.733 168.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -68.09 -49.7 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -175.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.39 55.91 0.82 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.984 1.265 . . . . 0.0 110.634 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.63 -67.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.666 3.986 . . . . 0.0 107.234 -161.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.54 -5.38 16.4 Favored Glycine 0 C--N 1.345 1.067 0 C-N-CA 124.65 1.119 . . . . 0.0 114.284 -166.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.521 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.0 t90 -48.02 -45.45 31.9 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.717 1.607 . . . . 0.0 109.854 172.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.84 -23.96 65.22 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 124.525 1.141 . . . . 0.0 111.441 -166.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.09 -10.05 80.83 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.583 -1.121 . . . . 0.0 113.268 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.4 mmm -122.07 12.61 10.39 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.503 1.521 . . . . 0.0 111.942 -173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 mm -73.39 -51.29 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 p30 32.3 13.78 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 1 C-N-CA 134.191 4.997 . . . . 0.0 120.689 171.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.059 0 C-N-CA 126.401 1.953 . . . . 0.0 113.602 -179.866 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.8 p . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.05 -32.56 72.19 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 170.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -59.33 -46.67 87.96 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.151 0.58 . . . . 0.0 110.889 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.93 -44.13 55.67 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.088 -0.84 . . . . 0.0 111.99 170.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.73 -32.37 73.63 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.742 1.271 . . . . 0.0 112.718 176.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.0 mt -70.36 -92.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.819 2.047 . . . . 0.0 108.571 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.49 -43.26 55.55 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.506 1.922 . . . . 0.0 111.567 -172.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.78 -21.78 73.3 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.583 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -71.75 -51.14 24.31 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.134 1.467 . . . . 0.0 109.079 165.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.417 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.5 mt -55.07 -44.01 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 125.733 1.613 . . . . 0.0 109.019 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.49 -3.98 0.13 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.433 1.493 . . . . 0.0 114.278 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.53 -56.25 1.4 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.171 1.389 . . . . 0.0 110.849 158.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.86 -7.28 88.4 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.398 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.417 ' HB2' HG23 ' A' ' 10' ' ' ILE . 20.5 t90 -53.56 -51.44 62.91 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 124.668 1.187 . . . . 0.0 110.852 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.81 -20.08 61.9 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 123.918 0.761 . . . . 0.0 111.638 -163.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.43 -5.94 89.55 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.409 -1.217 . . . . 0.0 113.209 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.3 mmm -128.1 16.3 6.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.425 1.89 . . . . 0.0 111.838 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mm -62.87 -31.3 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.894 0.878 . . . . 0.0 110.802 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 49.57 14.38 0.11 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 129.96 3.304 . . . . 0.0 117.156 165.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.983 0 C-N-CA 125.118 1.342 . . . . 0.0 113.641 -174.916 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.87 -34.78 73.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.711 0.404 . . . . 0.0 110.119 170.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.82 -45.64 92.95 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.65 0.38 . . . . 0.0 110.689 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.98 -48.79 37.67 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.174 0.892 . . . . 0.0 111.609 168.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.78 76.33 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.233 1.016 . . . . 0.0 112.784 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.257 96.5 mt -65.27 -92.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.59 1.956 . . . . 0.0 108.555 167.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.54 -39.36 48.95 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.527 1.931 . . . . 0.0 112.318 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.32 -22.86 77.68 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.574 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -71.75 -48.25 48.1 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.16 1.48 . . . . 0.0 109.076 164.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.8 mt -59.19 -45.36 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 C-N-CA 125.213 1.405 . . . . 0.0 108.822 -173.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -61.89 4.72 0.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.106 1.321 . . . . 0.0 114.252 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.86 -54.85 1.4 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.721 1.608 . . . . 0.0 109.872 158.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.82 -10.74 84.73 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.967 -0.907 . . . . 0.0 114.496 -167.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.484 ' HB2' HG23 ' A' ' 10' ' ' ILE . 19.3 t90 -56.86 -53.53 56.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.169 1.388 . . . . 0.0 110.429 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -69.83 -29.61 66.92 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.902 0.751 . . . . 0.0 110.745 -161.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.31 4.84 46.93 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.242 -1.31 . . . . 0.0 113.832 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 70.2 mtp -132.9 11.83 4.32 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.317 1.447 . . . . 0.0 112.204 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 mm -65.73 -36.26 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.219 0.918 . . . . 0.0 110.474 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 47.82 15.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 130.65 3.58 . . . . 0.0 117.537 164.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.925 0 C-N-CA 124.854 1.216 . . . . 0.0 113.299 -171.882 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -30.85 71.89 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 171.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -56.7 -43.76 80.84 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.436 0.695 . . . . 0.0 110.676 170.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.34 -21.12 46.97 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.875 1.226 . . . . 0.0 114.313 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.25 -19.96 20.24 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.634 1.717 . . . . 0.0 112.322 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.1 mt -86.1 -93.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.009 2.124 . . . . 0.0 107.126 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.74 -43.14 80.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.117 1.767 . . . . 0.0 110.397 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.29 -21.17 71.97 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.682 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -76.51 -52.42 9.81 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.781 1.291 . . . . 0.0 109.427 165.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.7 mt -54.87 -41.69 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 126.048 1.739 . . . . 0.0 109.382 -173.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -59.1 -2.65 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.15 -56.61 1.43 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.54 1.536 . . . . 0.0 110.504 158.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.79 -2.67 88.62 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.283 0.944 . . . . 0.0 114.609 -166.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.477 ' HB2' HG23 ' A' ' 10' ' ' ILE . 18.0 t90 -57.08 -49.02 77.15 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 118.471 1.135 . . . . 0.0 110.947 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.26 -33.72 75.93 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 123.686 0.616 . . . . 0.0 110.937 -163.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.86 4.48 45.14 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.665 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -133.13 12.99 4.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.216 1.806 . . . . 0.0 111.463 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -61.48 -38.37 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 121.344 -0.848 . . . . 0.0 110.427 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 48.04 14.8 0.06 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 130.362 3.465 . . . . 0.0 117.275 166.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.896 0 C-N-CA 125.794 1.664 . . . . 0.0 113.888 -172.685 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -32.76 72.01 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.13 -46.89 82.16 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.877 -0.515 . . . . 0.0 110.705 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.46 -49.43 39.13 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.983 0.801 . . . . 0.0 111.237 169.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.95 -35.05 78.86 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 117.995 0.898 . . . . 0.0 112.581 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.267 74.7 mt -63.63 -92.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 126.78 2.032 . . . . 0.0 108.575 167.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.45 -41.45 20.5 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.854 2.062 . . . . 0.0 112.091 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.8 -25.39 71.79 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 119.832 1.196 . . . . 0.0 113.916 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -41.24 61.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.898 1.349 . . . . 0.0 109.849 169.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -64.94 -48.05 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 124.959 1.304 . . . . 0.0 108.03 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.7 42.65 0.06 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 127.044 2.137 . . . . 0.0 112.633 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -160.7 -65.46 0.06 Allowed 'General case' 0 N--CA 1.452 -0.358 1 C-N-CA 132.664 4.386 . . . . 0.0 106.805 -176.712 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.91 -7.25 25.56 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 118.931 -0.927 . . . . 0.0 114.201 -165.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.525 ' HB2' HG23 ' A' ' 10' ' ' ILE . 19.6 t90 -47.82 -43.87 28.35 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.336 1.454 . . . . 0.0 110.553 174.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.03 -12.34 60.59 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.021 0.826 . . . . 0.0 111.987 -166.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.38 -0.65 72.99 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.999 0.809 . . . . 0.0 112.867 168.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 91.8 mmm -129.59 8.86 5.43 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.095 2.158 . . . . 0.0 111.922 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 20' ' ' GLY . 2.9 mm -53.95 -38.0 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.203 1.401 . . . . 0.0 110.289 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.6 13.89 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.7 2.0 . . . . 0.0 113.803 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 18' ' ' ILE . . . . . . . . 0 CA--C 1.535 1.293 0 C-N-CA 128.4 2.905 . . . . 0.0 111.869 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.29 -33.65 73.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.785 0.326 . . . . 0.0 110.328 172.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -63.61 -44.42 94.01 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.731 0.413 . . . . 0.0 110.933 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.61 -49.06 47.98 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.207 168.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.77 83.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.06 0.93 . . . . 0.0 112.521 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.293 90.1 mt -57.11 -92.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.957 2.103 . . . . 0.0 108.953 164.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.05 -38.26 7.72 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.773 2.029 . . . . 0.0 113.064 -170.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.5 -25.06 76.28 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.829 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.81 -36.86 62.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.033 1.416 . . . . 0.0 110.004 168.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -70.02 -54.59 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 125.148 1.379 . . . . 0.0 108.537 -174.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.4 69.54 0.39 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.487 1.915 . . . . 0.0 110.906 -172.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.34 -59.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 127.694 2.398 . . . . 0.0 108.689 -160.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.09 4.81 0.24 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.123 1.344 . . . . 0.0 112.863 -164.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.459 ' HB2' HG23 ' A' ' 10' ' ' ILE . 10.5 t90 -43.15 -38.95 2.64 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 126.391 1.876 . . . . 0.0 111.481 165.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.77 -34.05 77.02 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.916 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.5 -9.4 73.58 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.577 1.084 . . . . 0.0 113.049 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.2 mmm -102.18 3.84 38.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.428 1.491 . . . . 0.0 111.232 169.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -104.57 -80.13 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 171.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -150.15 14.04 0.79 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.644 1.178 . . . . 0.0 112.051 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 C-N-CA 125.253 1.406 . . . . 0.0 114.24 -167.146 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 p . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.38 -32.86 71.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.637 0.375 . . . . 0.0 110.088 170.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -61.81 -47.2 86.2 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.048 0.539 . . . . 0.0 110.841 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.88 -49.94 33.84 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.059 0.838 . . . . 0.0 111.342 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.42 -21.49 66.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.187 0.993 . . . . 0.0 113.542 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.25 77.4 mt -82.24 -92.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 126.941 2.096 . . . . 0.0 107.708 169.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.66 -39.56 17.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.3 2.24 . . . . 0.0 112.933 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.01 -14.42 82.24 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.993 0.806 . . . . 0.0 113.715 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -45.55 13.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.462 1.131 . . . . 0.0 108.551 163.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.427 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.8 mt -58.29 -42.91 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 C-N-CA 125.369 1.468 . . . . 0.0 109.2 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.14 0.11 0.19 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.29 -55.29 1.45 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.306 1.442 . . . . 0.0 110.545 159.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.41 -9.05 87.07 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.12 -0.822 . . . . 0.0 114.535 -166.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.427 ' HB2' HG23 ' A' ' 10' ' ' ILE . 22.5 t90 -59.87 -56.0 27.15 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.905 1.282 . . . . 0.0 111.004 177.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.73 -25.64 63.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.887 -158.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.44 -1.43 76.03 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.555 -1.136 . . . . 0.0 113.698 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.3 mtm -135.95 22.49 3.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.061 1.745 . . . . 0.0 111.476 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -63.03 -34.79 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.084 0.954 . . . . 0.0 110.709 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 48.9 14.29 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 130.107 3.363 . . . . 0.0 117.055 168.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 C-N-CA 126.005 1.764 . . . . 0.0 113.663 -175.575 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -32.43 73.01 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 171.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.78 -45.75 91.22 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 121.936 -0.478 . . . . 0.0 110.701 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.34 -48.92 39.91 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.189 0.9 . . . . 0.0 111.53 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.21 -32.55 73.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.577 1.188 . . . . 0.0 112.67 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.262 68.5 mt -68.75 -92.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.869 2.068 . . . . 0.0 108.585 169.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.51 -38.49 20.37 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 127.082 2.153 . . . . 0.0 113.117 -172.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.26 79.84 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.065 0.84 . . . . 0.0 113.818 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -78.34 -50.02 12.55 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.79 1.295 . . . . 0.0 108.639 161.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.88 -41.82 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 125.284 1.434 . . . . 0.0 110.115 -173.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.17 -1.63 0.34 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.207 1.367 . . . . 0.0 114.459 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.13 -58.04 1.38 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.002 1.321 . . . . 0.0 110.575 159.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.88 -6.87 87.43 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.392 -165.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -54.14 -52.78 60.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.616 1.167 . . . . 0.0 111.01 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.36 -22.65 62.76 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.843 0.714 . . . . 0.0 111.495 -162.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.7 -0.59 89.51 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.36 -1.244 . . . . 0.0 113.446 173.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.1 mtt -137.96 23.05 2.84 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.619 1.568 . . . . 0.0 111.31 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mm -58.58 -39.8 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.503 1.121 . . . . 0.0 110.929 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 46.59 14.27 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 130.977 3.711 . . . . 0.0 117.602 167.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.065 0 C-N-CA 125.58 1.562 . . . . 0.0 114.044 -176.81 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.21 -37.77 75.47 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 110.267 169.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.83 -45.17 90.65 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.219 0.533 . . . . 0.0 110.529 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.82 -36.09 59.33 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.703 1.144 . . . . 0.0 113.067 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.21 -27.5 53.5 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.377 1.589 . . . . 0.0 112.579 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -85.99 -93.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.398 1.879 . . . . 0.0 108.461 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.13 -38.22 76.09 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.034 1.734 . . . . 0.0 110.631 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.02 -22.52 75.93 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.862 -0.965 . . . . 0.0 113.463 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.81 -48.96 33.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.009 1.405 . . . . 0.0 109.165 165.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -58.91 -44.63 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 125.314 1.446 . . . . 0.0 108.729 -173.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -64.72 9.47 0.09 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 120.317 1.417 . . . . 0.0 114.099 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.13 -56.4 1.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.908 2.083 . . . . 0.0 109.364 158.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.1 -9.68 84.87 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.254 -0.748 . . . . 0.0 114.67 -166.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.546 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.2 t90 -58.01 -45.89 86.15 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 125.213 1.405 . . . . 0.0 110.988 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.44 -32.8 74.39 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 123.842 0.714 . . . . 0.0 111.035 -163.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.71 1.69 51.87 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.626 -1.097 . . . . 0.0 113.687 174.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.42 15.16 5.01 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.401 1.88 . . . . 0.0 111.212 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 mm -67.03 -44.62 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.326 -0.859 . . . . 0.0 109.486 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 51.48 15.27 0.32 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.086 2.555 . . . . 0.0 115.786 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.072 0 C-N-CA 125.582 1.563 . . . . 0.0 113.933 -174.655 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.83 -32.6 71.98 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 170.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -62.77 -47.28 84.17 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 122.035 -0.416 . . . . 0.0 110.81 173.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.16 -48.9 38.67 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 123.98 0.8 . . . . 0.0 111.254 169.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.35 77.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.924 0.862 . . . . 0.0 112.764 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.268 70.8 mt -62.55 -92.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.82 2.048 . . . . 0.0 108.492 166.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.81 -40.51 29.45 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.707 2.003 . . . . 0.0 112.48 -169.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.14 77.19 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 119.737 1.153 . . . . 0.0 113.377 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -37.61 83.09 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.711 1.256 . . . . 0.0 110.107 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mt -69.02 -54.4 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 C-N-CA 125.211 1.404 . . . . 0.0 108.678 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.82 59.82 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 129.16 2.984 . . . . 0.0 112.291 -173.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -172.18 -64.86 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.745 2.418 . . . . 0.0 108.603 -162.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.53 -1.9 1.59 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.89 1.233 . . . . 0.0 113.412 -166.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -40.37 -45.91 2.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 126.086 1.754 . . . . 0.0 111.189 168.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.75 -14.97 62.64 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.2 0.937 . . . . 0.0 112.071 -170.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.48 4.37 76.48 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.449 1.023 . . . . 0.0 112.806 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.9 mtm -135.04 17.6 3.47 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.083 2.153 . . . . 0.0 111.118 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mm -60.76 -35.73 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.944 1.298 . . . . 0.0 110.863 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 45.03 14.64 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 131.447 3.899 . . . . 0.0 118.005 165.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.072 0 C-N-CA 125.308 1.432 . . . . 0.0 114.004 -178.007 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.48 -33.6 72.83 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 171.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.5 -47.08 85.53 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 122.682 0.393 . . . . 0.0 110.815 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.14 -46.12 56.7 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.404 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.66 -35.88 82.0 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.474 1.137 . . . . 0.0 112.459 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.276 86.0 mt -60.35 -92.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.635 1.974 . . . . 0.0 108.568 165.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.67 -40.4 9.11 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.281 2.232 . . . . 0.0 112.568 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.23 -28.95 74.16 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.859 1.208 . . . . 0.0 113.673 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -37.7 77.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.935 1.367 . . . . 0.0 109.906 170.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.428 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.7 mt -68.3 -52.47 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 125.026 1.331 . . . . 0.0 108.431 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.62 54.56 0.08 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.176 2.59 . . . . 0.0 112.357 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -175.03 -69.09 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 129.558 3.143 . . . . 0.0 108.038 -163.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.13 -4.71 9.17 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 124.792 1.187 . . . . 0.0 113.852 -167.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.428 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.1 t90 -44.04 -45.14 7.82 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 125.964 1.706 . . . . 0.0 111.097 171.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.08 -11.14 60.44 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.073 0.858 . . . . 0.0 112.067 -169.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.93 2.64 69.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.212 0.911 . . . . 0.0 112.797 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.9 mmt -130.6 8.04 4.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.697 1.999 . . . . 0.0 111.474 -172.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mm -55.29 -41.12 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.323 1.449 . . . . 0.0 110.166 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.3 16.17 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 129.543 3.137 . . . . 0.0 114.683 -173.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.191 0 C-N-CA 125.782 1.658 . . . . 0.0 113.535 178.396 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.77 -33.13 72.49 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.171 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -63.93 -45.49 89.0 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 122.587 0.355 . . . . 0.0 110.715 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.86 -47.9 38.43 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.451 168.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.16 -41.86 98.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.587 1.193 . . . . 0.0 112.303 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.295 89.9 mt -54.88 -92.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 127.157 2.183 . . . . 0.0 109.391 167.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -44.62 -42.15 7.2 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.604 1.961 . . . . 0.0 112.622 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.35 -26.63 74.15 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.573 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -69.07 -50.45 48.26 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.266 1.533 . . . . 0.0 109.036 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mt -56.6 -42.8 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 125.262 1.425 . . . . 0.0 109.369 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -59.16 -2.25 0.26 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.0 -57.7 1.31 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.109 1.363 . . . . 0.0 110.748 159.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.87 -5.05 89.64 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.882 -0.954 . . . . 0.0 114.414 -165.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -55.61 -53.68 53.48 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 118.545 1.172 . . . . 0.0 110.881 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.01 -24.46 61.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.342 -164.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.69 10.96 28.69 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.503 1.525 . . . . 0.0 113.593 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.0 mmt -124.65 -10.95 7.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.828 1.251 . . . . 0.0 112.786 165.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mm -75.41 -26.57 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.212 1.405 . . . . 0.0 110.91 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -68.84 16.46 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.63 2.372 . . . . 0.0 112.954 172.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.223 0 C-N-CA 125.719 1.628 . . . . 0.0 114.305 -175.77 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.09 -34.31 73.29 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.121 0.569 . . . . 0.0 110.751 171.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.93 -45.63 91.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.786 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.43 -48.14 49.28 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.295 168.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.37 -34.24 77.29 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.491 1.146 . . . . 0.0 112.852 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.28 96.5 mt -60.72 -92.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.693 1.997 . . . . 0.0 108.648 164.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.45 -36.99 7.14 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.165 2.186 . . . . 0.0 113.266 -170.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.16 -26.21 72.79 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.453 1.024 . . . . 0.0 113.703 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -38.15 73.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.118 1.459 . . . . 0.0 109.46 167.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.17 -56.19 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 124.937 1.295 . . . . 0.0 110.141 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -68.86 65.38 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.83 2.852 . . . . 0.0 110.691 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.94 -51.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.349 1.86 . . . . 0.0 109.017 -163.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.88 -4.19 0.07 OUTLIER Glycine 0 C--N 1.34 0.775 0 CA-C-O 117.604 -1.665 . . . . 0.0 115.011 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.548 ' NE1' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -57.81 -36.62 72.47 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 120.162 1.981 . . . . 0.0 110.042 173.18 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.4 -29.82 70.17 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.489 -173.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.21 7.72 21.61 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.857 1.218 . . . . 0.0 113.845 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 48.0 mtt -130.53 6.62 4.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.26 1.424 . . . . 0.0 111.879 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.548 HD11 ' NE1' ' A' ' 14' ' ' TRP . 29.3 mm -72.63 -34.07 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.974 0.91 . . . . 0.0 111.21 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 50.11 17.27 0.3 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.605 3.162 . . . . 0.0 116.091 167.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 C-N-CA 125.86 1.695 . . . . 0.0 113.666 -173.08 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -32.78 73.81 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 170.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -55.58 -45.68 77.33 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.695 0.798 . . . . 0.0 110.872 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.23 -24.37 55.15 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.581 -1.122 . . . . 0.0 114.04 172.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.83 -18.1 30.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.571 1.686 . . . . 0.0 112.356 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.0 mt -86.29 -93.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 126.951 2.1 . . . . 0.0 107.474 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.28 -45.5 72.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.372 1.869 . . . . 0.0 110.522 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.3 -13.61 65.25 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 119.004 0.82 . . . . 0.0 114.272 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.03 -46.28 13.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.754 1.277 . . . . 0.0 109.583 164.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -54.76 -51.94 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.058 1.743 . . . . 0.0 111.171 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -67.1 47.87 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 130.871 3.668 . . . . 0.0 113.314 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -145.17 -56.06 0.32 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.193 2.197 . . . . 0.0 109.296 -172.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.36 -4.82 0.45 Allowed Glycine 0 C--N 1.341 0.822 0 CA-C-O 118.047 -1.418 . . . . 0.0 114.112 -170.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.547 ' NE1' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -57.29 -31.51 65.71 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 119.589 1.694 . . . . 0.0 110.756 173.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.92 -30.67 68.01 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.88 0.872 . . . . 0.0 111.748 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.71 8.91 12.31 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.905 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.6 mtt -130.5 5.89 4.77 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.693 1.597 . . . . 0.0 112.001 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.547 HD11 ' NE1' ' A' ' 14' ' ' TRP . 25.6 mm -73.69 -31.69 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.084 0.954 . . . . 0.0 111.417 -175.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 49.75 14.48 0.12 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 130.416 3.486 . . . . 0.0 117.159 164.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.003 0 C-N-CA 125.708 1.623 . . . . 0.0 114.022 -174.979 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.96 -35.15 74.34 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.007 0.432 . . . . 0.0 110.472 171.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.31 -46.02 90.61 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.635 173.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.0 -46.8 49.98 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.487 168.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.08 -34.83 78.93 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.671 1.236 . . . . 0.0 112.652 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.274 97.2 mt -61.86 -92.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.811 2.044 . . . . 0.0 109.023 166.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.24 -42.75 21.02 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.333 1.853 . . . . 0.0 112.077 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.27 -23.24 76.38 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 119.573 1.079 . . . . 0.0 113.612 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.62 -49.17 50.46 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.153 1.477 . . . . 0.0 108.992 165.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.7 mt -55.23 -45.54 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 125.293 1.437 . . . . 0.0 108.932 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -57.11 -1.21 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.59 1.556 . . . . 0.0 114.36 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -125.29 -56.61 1.52 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.123 1.369 . . . . 0.0 110.334 158.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.11 -8.33 87.47 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.056 -0.858 . . . . 0.0 114.666 -165.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.727 ' CD1' HD11 ' A' ' 18' ' ' ILE . 21.6 t90 -53.45 -57.0 12.21 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 125.526 1.53 . . . . 0.0 110.381 175.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.599 ' HA ' HD13 ' A' ' 18' ' ' ILE . 47.6 mt-10 -70.32 3.49 2.88 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -158.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.15 2.24 59.53 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.331 -1.26 . . . . 0.0 113.644 166.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.8 mtm -125.7 -7.52 6.78 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.428 1.614 . . . . 0.0 115.344 -167.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.727 HD11 ' CD1' ' A' ' 14' ' ' TRP . 3.0 mp -65.9 -37.87 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.835 1.254 . . . . 0.0 110.294 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.95 22.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.425 3.09 . . . . 0.0 114.161 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 C-N-CA 125.217 1.389 . . . . 0.0 114.527 -173.47 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 tt -58.08 -36.81 73.38 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.073 0.549 . . . . 0.0 110.572 168.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.24 -46.16 90.74 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.719 173.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.85 -46.5 48.88 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.957 -0.913 . . . . 0.0 112.074 169.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.01 -25.27 67.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.773 1.286 . . . . 0.0 113.039 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.12 -92.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 126.662 1.985 . . . . 0.0 107.972 167.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.81 -42.06 16.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.542 2.337 . . . . 0.0 112.615 -171.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.65 -14.4 77.86 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.409 1.004 . . . . 0.0 113.943 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -40.5 23.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.77 1.285 . . . . 0.0 109.462 163.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.58 -53.05 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.449 1.5 . . . . 0.0 111.293 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.3 64.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.824 2.85 . . . . 0.0 111.949 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -160.54 -54.53 0.05 Allowed 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 126.817 2.047 . . . . 0.0 110.02 -167.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.46 10.58 0.06 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.593 -1.115 . . . . 0.0 113.391 -171.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -20.29 46.55 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.455 1.627 . . . . 0.0 111.753 172.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -54.36 -31.69 55.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.863 1.265 . . . . 0.0 111.368 173.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.57 -11.26 47.72 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.51 -0.744 . . . . 0.0 113.507 173.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.0 mmm -109.54 -3.63 16.81 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.46 1.904 . . . . 0.0 112.243 171.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt -84.99 -37.85 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.296 1.438 . . . . 0.0 108.637 167.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -69.06 71.14 0.23 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.421 1.489 . . . . 0.0 110.871 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 C-N-CA 125.478 1.513 . . . . 0.0 110.625 178.001 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.3 p . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tt -58.55 -36.32 73.71 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.144 0.497 . . . . 0.0 110.517 169.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.49 -44.44 94.33 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.628 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.39 -48.16 42.02 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.265 0.936 . . . . 0.0 111.704 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.58 75.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.786 1.293 . . . . 0.0 112.604 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.263 98.1 mt -63.95 -92.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.704 2.002 . . . . 0.0 108.75 166.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.41 -42.79 15.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.93 2.092 . . . . 0.0 112.273 -170.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.1 -23.04 71.14 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 119.44 1.018 . . . . 0.0 113.59 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -46.71 50.24 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.818 1.309 . . . . 0.0 109.415 167.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.6 mt -57.84 -43.75 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.537 1.535 . . . . 0.0 108.553 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -57.19 -2.75 0.11 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.253 1.421 . . . . 0.0 114.342 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.1 -54.66 1.49 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.088 1.355 . . . . 0.0 110.634 158.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.93 -8.17 87.97 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.029 -0.873 . . . . 0.0 114.513 -166.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.464 ' HB2' HG23 ' A' ' 10' ' ' ILE . 18.4 t90 -56.01 -47.51 77.64 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.511 1.155 . . . . 0.0 111.203 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.28 -18.87 61.77 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.65 0.594 . . . . 0.0 112.235 -161.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.63 -3.94 90.3 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.206 -0.774 . . . . 0.0 113.085 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 89.0 mmm -129.0 9.28 5.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.375 1.87 . . . . 0.0 111.84 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm . . . . . 0 N--CA 1.466 0.341 0 C-N-CA 124.831 1.252 . . . . 0.0 110.145 -177.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.45 -34.18 73.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.206 0.527 . . . . 0.0 110.468 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -63.3 -44.22 95.63 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.778 173.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.45 -48.67 41.27 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.013 -0.882 . . . . 0.0 111.553 167.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.13 84.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.798 1.299 . . . . 0.0 112.529 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.285 96.8 mt -58.42 -92.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.991 2.116 . . . . 0.0 109.152 166.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.86 -37.05 8.18 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.819 2.048 . . . . 0.0 113.168 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.01 -18.86 79.77 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.573 1.082 . . . . 0.0 113.967 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.87 -48.1 19.33 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.983 1.392 . . . . 0.0 108.796 161.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.8 mt -58.85 -43.61 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.322 1.449 . . . . 0.0 109.278 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.74 -0.95 0.33 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 120.236 1.38 . . . . 0.0 114.4 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -122.62 -56.73 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.912 1.285 . . . . 0.0 110.45 159.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.79 -8.31 87.8 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.899 -0.945 . . . . 0.0 114.801 -166.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.46 ' HB2' HG23 ' A' ' 10' ' ' ILE . 18.6 t90 -55.59 -48.8 74.24 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.83 1.252 . . . . 0.0 111.018 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -75.42 -15.79 60.41 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.746 -159.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.3 -2.03 83.39 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.139 -0.812 . . . . 0.0 112.959 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 92.0 mmm -125.81 5.26 7.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.838 1.655 . . . . 0.0 111.973 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mm . . . . . 0 CA--C 1.532 0.286 0 C-N-CA 124.696 1.199 . . . . 0.0 110.115 -178.847 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 tt -58.42 -36.55 73.78 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.043 0.537 . . . . 0.0 110.914 170.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.37 -41.07 89.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.814 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.46 -48.37 65.17 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 119.101 -0.833 . . . . 0.0 111.406 165.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.37 -32.05 73.37 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.586 1.193 . . . . 0.0 112.473 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.273 95.9 mt -60.63 -92.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.774 2.03 . . . . 0.0 108.279 162.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -51.14 -39.28 55.91 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.231 1.813 . . . . 0.0 113.304 -165.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.92 -17.49 79.38 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.339 0.971 . . . . 0.0 113.549 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.17 -50.59 9.41 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.44 1.12 . . . . 0.0 108.737 162.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mt -56.63 -40.33 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 125.694 1.598 . . . . 0.0 110.307 -173.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.01 -3.03 0.49 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.799 1.181 . . . . 0.0 113.96 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -123.97 -60.52 1.43 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.332 1.453 . . . . 0.0 110.385 159.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.62 84.36 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.535 1.064 . . . . 0.0 114.582 -164.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 t90 -53.31 -41.79 66.03 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.379 1.09 . . . . 0.0 111.543 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.04 -36.63 84.21 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.749 0.656 . . . . 0.0 111.269 -164.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.17 -1.11 62.86 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.798 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 mmt -119.48 3.33 11.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.08 1.752 . . . . 0.0 111.706 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm . . . . . 0 C--N 1.342 0.281 0 C-N-CA 123.782 0.833 . . . . 0.0 109.264 177.928 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.5 p . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -32.72 72.33 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 170.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -60.83 -47.01 88.29 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 122.969 0.508 . . . . 0.0 110.774 172.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.37 -48.68 47.47 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.873 0.749 . . . . 0.0 111.565 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.02 -20.27 65.79 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.5 mt -86.12 -93.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 126.4 1.88 . . . . 0.0 108.004 168.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.54 79.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.432 2.293 . . . . 0.0 112.614 -169.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.79 -38.73 66.15 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 119.13 0.877 . . . . 0.0 111.845 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -44.65 93.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.876 0.87 . . . . 0.0 110.419 167.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -64.01 -53.41 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 124.681 1.192 . . . . 0.0 108.754 -176.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -70.64 63.88 0.28 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.964 1.706 . . . . 0.0 111.626 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.9 -61.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 129.249 3.02 . . . . 0.0 108.646 -163.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.26 -4.27 4.09 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.059 1.314 . . . . 0.0 113.573 -168.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.525 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.3 t90 -46.38 -40.11 11.46 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 126.168 1.787 . . . . 0.0 110.807 170.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.07 -19.47 65.66 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.783 0.677 . . . . 0.0 112.106 -172.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.22 2.02 83.13 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.063 0.84 . . . . 0.0 112.959 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.6 mmt -128.2 6.54 5.9 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.083 2.153 . . . . 0.0 111.464 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 mm . . . . . 0 CA--C 1.535 0.376 0 C-N-CA 124.835 1.254 . . . . 0.0 109.85 177.473 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.4 p . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.93 -34.16 72.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.844 0.458 . . . . 0.0 110.321 170.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -62.83 -44.39 96.28 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 122.977 0.511 . . . . 0.0 110.672 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.52 -47.76 50.77 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.949 -0.917 . . . . 0.0 111.479 168.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.99 91.87 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.542 1.171 . . . . 0.0 112.434 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.287 96.6 mt -56.55 -92.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.884 2.073 . . . . 0.0 109.017 165.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.0 -37.26 3.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 127.403 2.281 . . . . 0.0 113.131 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.06 -28.37 73.0 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.683 1.129 . . . . 0.0 113.601 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.66 -39.04 67.45 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.899 1.35 . . . . 0.0 109.733 168.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -68.09 -49.7 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -175.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.39 55.91 0.82 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.984 1.265 . . . . 0.0 110.634 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.63 -67.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.666 3.986 . . . . 0.0 107.234 -161.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.54 -5.38 16.4 Favored Glycine 0 C--N 1.345 1.067 0 C-N-CA 124.65 1.119 . . . . 0.0 114.284 -166.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.521 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.0 t90 -48.02 -45.45 31.9 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.717 1.607 . . . . 0.0 109.854 172.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.84 -23.96 65.22 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 124.525 1.141 . . . . 0.0 111.441 -166.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.09 -10.05 80.83 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.583 -1.121 . . . . 0.0 113.268 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.4 mmm -122.07 12.61 10.39 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.503 1.521 . . . . 0.0 111.942 -173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 mm . . . . . 0 CA--C 1.535 0.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.259 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.8 p . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.05 -32.56 72.19 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 170.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -59.33 -46.67 87.96 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.151 0.58 . . . . 0.0 110.889 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.93 -44.13 55.67 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.088 -0.84 . . . . 0.0 111.99 170.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.73 -32.37 73.63 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.742 1.271 . . . . 0.0 112.718 176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.0 mt -70.36 -92.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.819 2.047 . . . . 0.0 108.571 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.49 -43.26 55.55 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.506 1.922 . . . . 0.0 111.567 -172.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.78 -21.78 73.3 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.583 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -71.75 -51.14 24.31 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.134 1.467 . . . . 0.0 109.079 165.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.417 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.5 mt -55.07 -44.01 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 125.733 1.613 . . . . 0.0 109.019 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.49 -3.98 0.13 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.433 1.493 . . . . 0.0 114.278 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.53 -56.25 1.4 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.171 1.389 . . . . 0.0 110.849 158.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.86 -7.28 88.4 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.398 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.417 ' HB2' HG23 ' A' ' 10' ' ' ILE . 20.5 t90 -53.56 -51.44 62.91 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 124.668 1.187 . . . . 0.0 110.852 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.81 -20.08 61.9 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 123.918 0.761 . . . . 0.0 111.638 -163.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.43 -5.94 89.55 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.409 -1.217 . . . . 0.0 113.209 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.3 mmm -128.1 16.3 6.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.425 1.89 . . . . 0.0 111.838 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mm . . . . . 0 CA--C 1.54 0.575 0 C-N-CA 123.894 0.878 . . . . 0.0 110.802 -179.383 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.87 -34.78 73.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.711 0.404 . . . . 0.0 110.119 170.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.82 -45.64 92.95 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.65 0.38 . . . . 0.0 110.689 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.98 -48.79 37.67 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.174 0.892 . . . . 0.0 111.609 168.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.78 76.33 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.233 1.016 . . . . 0.0 112.784 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.257 96.5 mt -65.27 -92.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.59 1.956 . . . . 0.0 108.555 167.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.54 -39.36 48.95 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.527 1.931 . . . . 0.0 112.318 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.32 -22.86 77.68 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.574 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -71.75 -48.25 48.1 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.16 1.48 . . . . 0.0 109.076 164.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.8 mt -59.19 -45.36 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 C-N-CA 125.213 1.405 . . . . 0.0 108.822 -173.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -61.89 4.72 0.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.106 1.321 . . . . 0.0 114.252 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.86 -54.85 1.4 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.721 1.608 . . . . 0.0 109.872 158.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.82 -10.74 84.73 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.967 -0.907 . . . . 0.0 114.496 -167.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.484 ' HB2' HG23 ' A' ' 10' ' ' ILE . 19.3 t90 -56.86 -53.53 56.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.169 1.388 . . . . 0.0 110.429 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -69.83 -29.61 66.92 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.902 0.751 . . . . 0.0 110.745 -161.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.31 4.84 46.93 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.242 -1.31 . . . . 0.0 113.832 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 70.2 mtp -132.9 11.83 4.32 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.317 1.447 . . . . 0.0 112.204 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 mm . . . . . 0 CA--C 1.538 0.501 0 CA-C-N 119.219 0.918 . . . . 0.0 110.474 -179.229 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -30.85 71.89 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 171.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -56.7 -43.76 80.84 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.436 0.695 . . . . 0.0 110.676 170.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.34 -21.12 46.97 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.875 1.226 . . . . 0.0 114.313 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.25 -19.96 20.24 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.634 1.717 . . . . 0.0 112.322 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.1 mt -86.1 -93.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.009 2.124 . . . . 0.0 107.126 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.74 -43.14 80.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.117 1.767 . . . . 0.0 110.397 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.29 -21.17 71.97 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.682 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -76.51 -52.42 9.81 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.781 1.291 . . . . 0.0 109.427 165.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.7 mt -54.87 -41.69 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 126.048 1.739 . . . . 0.0 109.382 -173.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -59.1 -2.65 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.15 -56.61 1.43 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.54 1.536 . . . . 0.0 110.504 158.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.79 -2.67 88.62 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.283 0.944 . . . . 0.0 114.609 -166.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.477 ' HB2' HG23 ' A' ' 10' ' ' ILE . 18.0 t90 -57.08 -49.02 77.15 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 118.471 1.135 . . . . 0.0 110.947 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.26 -33.72 75.93 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 123.686 0.616 . . . . 0.0 110.937 -163.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.86 4.48 45.14 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.665 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -133.13 12.99 4.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.216 1.806 . . . . 0.0 111.463 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm . . . . . 0 CA--C 1.538 0.483 0 O-C-N 121.344 -0.848 . . . . 0.0 110.427 178.904 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -32.76 72.01 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.13 -46.89 82.16 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.877 -0.515 . . . . 0.0 110.705 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.46 -49.43 39.13 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.983 0.801 . . . . 0.0 111.237 169.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.95 -35.05 78.86 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 117.995 0.898 . . . . 0.0 112.581 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.267 74.7 mt -63.63 -92.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 126.78 2.032 . . . . 0.0 108.575 167.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.45 -41.45 20.5 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.854 2.062 . . . . 0.0 112.091 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.8 -25.39 71.79 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 119.832 1.196 . . . . 0.0 113.916 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -41.24 61.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.898 1.349 . . . . 0.0 109.849 169.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -64.94 -48.05 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 124.959 1.304 . . . . 0.0 108.03 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.7 42.65 0.06 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 127.044 2.137 . . . . 0.0 112.633 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -160.7 -65.46 0.06 Allowed 'General case' 0 N--CA 1.452 -0.358 1 C-N-CA 132.664 4.386 . . . . 0.0 106.805 -176.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.91 -7.25 25.56 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 118.931 -0.927 . . . . 0.0 114.201 -165.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.525 ' HB2' HG23 ' A' ' 10' ' ' ILE . 19.6 t90 -47.82 -43.87 28.35 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.336 1.454 . . . . 0.0 110.553 174.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.03 -12.34 60.59 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.021 0.826 . . . . 0.0 111.987 -166.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.38 -0.65 72.99 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.999 0.809 . . . . 0.0 112.867 168.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 91.8 mmm -129.59 8.86 5.43 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.095 2.158 . . . . 0.0 111.922 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.9 mm . . . . . 0 N--CA 1.465 0.303 0 C-N-CA 125.203 1.401 . . . . 0.0 110.289 -177.205 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.29 -33.65 73.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.785 0.326 . . . . 0.0 110.328 172.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -63.61 -44.42 94.01 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.731 0.413 . . . . 0.0 110.933 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.61 -49.06 47.98 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.207 168.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.77 83.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.06 0.93 . . . . 0.0 112.521 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.293 90.1 mt -57.11 -92.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.957 2.103 . . . . 0.0 108.953 164.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.05 -38.26 7.72 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.773 2.029 . . . . 0.0 113.064 -170.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.5 -25.06 76.28 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.829 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.81 -36.86 62.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.033 1.416 . . . . 0.0 110.004 168.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -70.02 -54.59 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 125.148 1.379 . . . . 0.0 108.537 -174.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.4 69.54 0.39 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.487 1.915 . . . . 0.0 110.906 -172.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.34 -59.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 127.694 2.398 . . . . 0.0 108.689 -160.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.09 4.81 0.24 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.123 1.344 . . . . 0.0 112.863 -164.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.459 ' HB2' HG23 ' A' ' 10' ' ' ILE . 10.5 t90 -43.15 -38.95 2.64 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 126.391 1.876 . . . . 0.0 111.481 165.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.77 -34.05 77.02 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.916 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.5 -9.4 73.58 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.577 1.084 . . . . 0.0 113.049 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.2 mmm -102.18 3.84 38.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.428 1.491 . . . . 0.0 111.232 169.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.44 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 171.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 p . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.38 -32.86 71.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.637 0.375 . . . . 0.0 110.088 170.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -61.81 -47.2 86.2 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.048 0.539 . . . . 0.0 110.841 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.88 -49.94 33.84 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.059 0.838 . . . . 0.0 111.342 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.42 -21.49 66.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.187 0.993 . . . . 0.0 113.542 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.25 77.4 mt -82.24 -92.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 126.941 2.096 . . . . 0.0 107.708 169.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.66 -39.56 17.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.3 2.24 . . . . 0.0 112.933 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.01 -14.42 82.24 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.993 0.806 . . . . 0.0 113.715 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -45.55 13.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.462 1.131 . . . . 0.0 108.551 163.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.427 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.8 mt -58.29 -42.91 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 C-N-CA 125.369 1.468 . . . . 0.0 109.2 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.14 0.11 0.19 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.29 -55.29 1.45 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.306 1.442 . . . . 0.0 110.545 159.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.41 -9.05 87.07 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.12 -0.822 . . . . 0.0 114.535 -166.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.427 ' HB2' HG23 ' A' ' 10' ' ' ILE . 22.5 t90 -59.87 -56.0 27.15 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.905 1.282 . . . . 0.0 111.004 177.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.73 -25.64 63.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.887 -158.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.44 -1.43 76.03 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.555 -1.136 . . . . 0.0 113.698 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.3 mtm -135.95 22.49 3.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.061 1.745 . . . . 0.0 111.476 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm . . . . . 0 CA--C 1.537 0.478 0 C-N-CA 124.084 0.954 . . . . 0.0 110.709 178.651 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -32.43 73.01 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 171.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.78 -45.75 91.22 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 121.936 -0.478 . . . . 0.0 110.701 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.34 -48.92 39.91 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.189 0.9 . . . . 0.0 111.53 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.21 -32.55 73.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.577 1.188 . . . . 0.0 112.67 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.262 68.5 mt -68.75 -92.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.869 2.068 . . . . 0.0 108.585 169.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.51 -38.49 20.37 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 127.082 2.153 . . . . 0.0 113.117 -172.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.26 79.84 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.065 0.84 . . . . 0.0 113.818 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -78.34 -50.02 12.55 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.79 1.295 . . . . 0.0 108.639 161.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.88 -41.82 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 125.284 1.434 . . . . 0.0 110.115 -173.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.17 -1.63 0.34 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.207 1.367 . . . . 0.0 114.459 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.13 -58.04 1.38 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.002 1.321 . . . . 0.0 110.575 159.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.88 -6.87 87.43 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.392 -165.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -54.14 -52.78 60.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.616 1.167 . . . . 0.0 111.01 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.36 -22.65 62.76 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.843 0.714 . . . . 0.0 111.495 -162.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.7 -0.59 89.51 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.36 -1.244 . . . . 0.0 113.446 173.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.1 mtt -137.96 23.05 2.84 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.619 1.568 . . . . 0.0 111.31 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mm . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 124.503 1.121 . . . . 0.0 110.929 179.244 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.21 -37.77 75.47 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 110.267 169.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.83 -45.17 90.65 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.219 0.533 . . . . 0.0 110.529 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.82 -36.09 59.33 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.703 1.144 . . . . 0.0 113.067 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.21 -27.5 53.5 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.377 1.589 . . . . 0.0 112.579 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -85.99 -93.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.398 1.879 . . . . 0.0 108.461 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.13 -38.22 76.09 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.034 1.734 . . . . 0.0 110.631 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.02 -22.52 75.93 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.862 -0.965 . . . . 0.0 113.463 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.81 -48.96 33.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.009 1.405 . . . . 0.0 109.165 165.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -58.91 -44.63 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 125.314 1.446 . . . . 0.0 108.729 -173.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -64.72 9.47 0.09 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 120.317 1.417 . . . . 0.0 114.099 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.13 -56.4 1.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.908 2.083 . . . . 0.0 109.364 158.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.1 -9.68 84.87 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.254 -0.748 . . . . 0.0 114.67 -166.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.546 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.2 t90 -58.01 -45.89 86.15 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 125.213 1.405 . . . . 0.0 110.988 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.44 -32.8 74.39 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 123.842 0.714 . . . . 0.0 111.035 -163.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.71 1.69 51.87 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.626 -1.097 . . . . 0.0 113.687 174.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.42 15.16 5.01 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.401 1.88 . . . . 0.0 111.212 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 mm . . . . . 0 CA--C 1.537 0.447 0 O-C-N 121.326 -0.859 . . . . 0.0 109.486 175.91 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.83 -32.6 71.98 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 170.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -62.77 -47.28 84.17 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 122.035 -0.416 . . . . 0.0 110.81 173.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.16 -48.9 38.67 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 123.98 0.8 . . . . 0.0 111.254 169.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.35 77.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.924 0.862 . . . . 0.0 112.764 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.268 70.8 mt -62.55 -92.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.82 2.048 . . . . 0.0 108.492 166.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.81 -40.51 29.45 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.707 2.003 . . . . 0.0 112.48 -169.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.14 77.19 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 119.737 1.153 . . . . 0.0 113.377 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -37.61 83.09 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.711 1.256 . . . . 0.0 110.107 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mt -69.02 -54.4 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 C-N-CA 125.211 1.404 . . . . 0.0 108.678 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.82 59.82 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 129.16 2.984 . . . . 0.0 112.291 -173.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -172.18 -64.86 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.745 2.418 . . . . 0.0 108.603 -162.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.53 -1.9 1.59 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.89 1.233 . . . . 0.0 113.412 -166.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -40.37 -45.91 2.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 126.086 1.754 . . . . 0.0 111.189 168.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.75 -14.97 62.64 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.2 0.937 . . . . 0.0 112.071 -170.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.48 4.37 76.48 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.449 1.023 . . . . 0.0 112.806 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.9 mtm -135.04 17.6 3.47 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.083 2.153 . . . . 0.0 111.118 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mm . . . . . 0 CA--C 1.539 0.528 0 C-N-CA 124.944 1.298 . . . . 0.0 110.863 -178.583 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.48 -33.6 72.83 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 171.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.5 -47.08 85.53 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 122.682 0.393 . . . . 0.0 110.815 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.14 -46.12 56.7 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.404 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.66 -35.88 82.0 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.474 1.137 . . . . 0.0 112.459 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.276 86.0 mt -60.35 -92.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.635 1.974 . . . . 0.0 108.568 165.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.67 -40.4 9.11 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.281 2.232 . . . . 0.0 112.568 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.23 -28.95 74.16 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.859 1.208 . . . . 0.0 113.673 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -37.7 77.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.935 1.367 . . . . 0.0 109.906 170.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.428 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.7 mt -68.3 -52.47 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 125.026 1.331 . . . . 0.0 108.431 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.62 54.56 0.08 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.176 2.59 . . . . 0.0 112.357 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -175.03 -69.09 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 129.558 3.143 . . . . 0.0 108.038 -163.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.13 -4.71 9.17 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 124.792 1.187 . . . . 0.0 113.852 -167.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.428 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.1 t90 -44.04 -45.14 7.82 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 125.964 1.706 . . . . 0.0 111.097 171.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.08 -11.14 60.44 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.073 0.858 . . . . 0.0 112.067 -169.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.93 2.64 69.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.212 0.911 . . . . 0.0 112.797 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.9 mmt -130.6 8.04 4.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.697 1.999 . . . . 0.0 111.474 -172.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mm . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 125.323 1.449 . . . . 0.0 110.166 -179.437 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.77 -33.13 72.49 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.171 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -63.93 -45.49 89.0 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 122.587 0.355 . . . . 0.0 110.715 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.86 -47.9 38.43 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.451 168.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.16 -41.86 98.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.587 1.193 . . . . 0.0 112.303 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.295 89.9 mt -54.88 -92.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 127.157 2.183 . . . . 0.0 109.391 167.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -44.62 -42.15 7.2 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.604 1.961 . . . . 0.0 112.622 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.35 -26.63 74.15 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.573 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -69.07 -50.45 48.26 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.266 1.533 . . . . 0.0 109.036 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mt -56.6 -42.8 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 125.262 1.425 . . . . 0.0 109.369 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -59.16 -2.25 0.26 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.0 -57.7 1.31 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.109 1.363 . . . . 0.0 110.748 159.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.87 -5.05 89.64 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.882 -0.954 . . . . 0.0 114.414 -165.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -55.61 -53.68 53.48 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 118.545 1.172 . . . . 0.0 110.881 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.01 -24.46 61.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.342 -164.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.69 10.96 28.69 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.503 1.525 . . . . 0.0 113.593 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.0 mmt -124.65 -10.95 7.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.828 1.251 . . . . 0.0 112.786 165.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mm . . . . . 0 CA--C 1.532 0.256 0 C-N-CA 125.212 1.405 . . . . 0.0 110.91 179.353 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.09 -34.31 73.29 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.121 0.569 . . . . 0.0 110.751 171.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.93 -45.63 91.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.786 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.43 -48.14 49.28 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.295 168.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.37 -34.24 77.29 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.491 1.146 . . . . 0.0 112.852 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.28 96.5 mt -60.72 -92.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.693 1.997 . . . . 0.0 108.648 164.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.45 -36.99 7.14 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.165 2.186 . . . . 0.0 113.266 -170.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.16 -26.21 72.79 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.453 1.024 . . . . 0.0 113.703 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -38.15 73.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.118 1.459 . . . . 0.0 109.46 167.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.17 -56.19 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 124.937 1.295 . . . . 0.0 110.141 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -68.86 65.38 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.83 2.852 . . . . 0.0 110.691 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.94 -51.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.349 1.86 . . . . 0.0 109.017 -163.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.88 -4.19 0.07 OUTLIER Glycine 0 C--N 1.34 0.775 0 CA-C-O 117.604 -1.665 . . . . 0.0 115.011 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.548 ' NE1' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -57.81 -36.62 72.47 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 120.162 1.981 . . . . 0.0 110.042 173.18 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.4 -29.82 70.17 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.489 -173.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.21 7.72 21.61 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.857 1.218 . . . . 0.0 113.845 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 48.0 mtt -130.53 6.62 4.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.26 1.424 . . . . 0.0 111.879 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.548 HD11 ' NE1' ' A' ' 14' ' ' TRP . 29.3 mm . . . . . 0 CA--C 1.533 0.313 0 C-N-CA 123.974 0.91 . . . . 0.0 111.21 -175.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -32.78 73.81 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 170.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -55.58 -45.68 77.33 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.695 0.798 . . . . 0.0 110.872 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.23 -24.37 55.15 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.581 -1.122 . . . . 0.0 114.04 172.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.83 -18.1 30.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.571 1.686 . . . . 0.0 112.356 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.0 mt -86.29 -93.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 126.951 2.1 . . . . 0.0 107.474 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.28 -45.5 72.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.372 1.869 . . . . 0.0 110.522 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.3 -13.61 65.25 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 119.004 0.82 . . . . 0.0 114.272 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.03 -46.28 13.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.754 1.277 . . . . 0.0 109.583 164.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -54.76 -51.94 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.058 1.743 . . . . 0.0 111.171 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -67.1 47.87 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 130.871 3.668 . . . . 0.0 113.314 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -145.17 -56.06 0.32 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.193 2.197 . . . . 0.0 109.296 -172.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.36 -4.82 0.45 Allowed Glycine 0 C--N 1.341 0.822 0 CA-C-O 118.047 -1.418 . . . . 0.0 114.112 -170.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.547 ' NE1' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -57.29 -31.51 65.71 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 119.589 1.694 . . . . 0.0 110.756 173.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.92 -30.67 68.01 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.88 0.872 . . . . 0.0 111.748 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.71 8.91 12.31 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.905 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.6 mtt -130.5 5.89 4.77 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.693 1.597 . . . . 0.0 112.001 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.547 HD11 ' NE1' ' A' ' 14' ' ' TRP . 25.6 mm . . . . . 0 CA--C 1.533 0.307 0 C-N-CA 124.084 0.954 . . . . 0.0 111.417 -175.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.96 -35.15 74.34 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.007 0.432 . . . . 0.0 110.472 171.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.31 -46.02 90.61 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.635 173.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.0 -46.8 49.98 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.487 168.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.08 -34.83 78.93 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.671 1.236 . . . . 0.0 112.652 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.274 97.2 mt -61.86 -92.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.811 2.044 . . . . 0.0 109.023 166.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.24 -42.75 21.02 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.333 1.853 . . . . 0.0 112.077 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.27 -23.24 76.38 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 119.573 1.079 . . . . 0.0 113.612 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.62 -49.17 50.46 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.153 1.477 . . . . 0.0 108.992 165.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.7 mt -55.23 -45.54 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 125.293 1.437 . . . . 0.0 108.932 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -57.11 -1.21 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.59 1.556 . . . . 0.0 114.36 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -125.29 -56.61 1.52 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.123 1.369 . . . . 0.0 110.334 158.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.11 -8.33 87.47 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.056 -0.858 . . . . 0.0 114.666 -165.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.727 ' CD1' HD11 ' A' ' 18' ' ' ILE . 21.6 t90 -53.45 -57.0 12.21 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 125.526 1.53 . . . . 0.0 110.381 175.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.599 ' HA ' HD13 ' A' ' 18' ' ' ILE . 47.6 mt-10 -70.32 3.49 2.88 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -158.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.15 2.24 59.53 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.331 -1.26 . . . . 0.0 113.644 166.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.8 mtm -125.7 -7.52 6.78 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.428 1.614 . . . . 0.0 115.344 -167.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.727 HD11 ' CD1' ' A' ' 14' ' ' TRP . 3.0 mp . . . . . 0 CA--C 1.534 0.343 0 C-N-CA 124.835 1.254 . . . . 0.0 110.294 -179.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 tt -58.08 -36.81 73.38 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.073 0.549 . . . . 0.0 110.572 168.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.24 -46.16 90.74 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.719 173.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.85 -46.5 48.88 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.957 -0.913 . . . . 0.0 112.074 169.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.01 -25.27 67.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.773 1.286 . . . . 0.0 113.039 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.12 -92.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 126.662 1.985 . . . . 0.0 107.972 167.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.81 -42.06 16.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.542 2.337 . . . . 0.0 112.615 -171.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.65 -14.4 77.86 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.409 1.004 . . . . 0.0 113.943 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -40.5 23.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.77 1.285 . . . . 0.0 109.462 163.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.58 -53.05 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.449 1.5 . . . . 0.0 111.293 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.3 64.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.824 2.85 . . . . 0.0 111.949 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -160.54 -54.53 0.05 Allowed 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 126.817 2.047 . . . . 0.0 110.02 -167.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.46 10.58 0.06 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.593 -1.115 . . . . 0.0 113.391 -171.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -20.29 46.55 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.455 1.627 . . . . 0.0 111.753 172.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -54.36 -31.69 55.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.863 1.265 . . . . 0.0 111.368 173.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.57 -11.26 47.72 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.51 -0.744 . . . . 0.0 113.507 173.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.0 mmm -109.54 -3.63 16.81 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.46 1.904 . . . . 0.0 112.243 171.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt . . . . . 0 CA--C 1.534 0.336 0 C-N-CA 125.296 1.438 . . . . 0.0 108.637 167.063 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 67.3 p . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.6 tt -58.55 -36.32 73.71 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 121.144 0.497 . . . . 0.0 110.517 169.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.49 -44.44 94.33 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.628 175.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.39 -48.16 42.02 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 124.265 0.936 . . . . 0.0 111.704 167.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.48 -33.58 75.89 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.786 1.293 . . . . 0.0 112.604 178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.263 98.1 mt -63.95 -92.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 C-N-CA 126.704 2.002 . . . . 0.0 108.75 166.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.41 -42.79 15.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 126.93 2.092 . . . . 0.0 112.273 -170.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.1 -23.04 71.14 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-N 119.44 1.018 . . . . 0.0 113.59 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -46.71 50.24 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.818 1.309 . . . . 0.0 109.415 167.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.464 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.6 mt -57.84 -43.75 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.537 1.535 . . . . 0.0 108.553 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -57.19 -2.75 0.11 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.253 1.421 . . . . 0.0 114.342 -178.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.1 -54.66 1.49 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.088 1.355 . . . . 0.0 110.634 158.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.93 -8.17 87.97 Favored Glycine 0 CA--C 1.529 0.951 0 CA-C-O 119.029 -0.873 . . . . 0.0 114.513 -166.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.464 ' HB2' HG23 ' A' ' 10' ' ' ILE . 18.4 t90 -56.01 -47.51 77.64 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 118.511 1.155 . . . . 0.0 111.203 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -72.28 -18.87 61.77 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 123.65 0.594 . . . . 0.0 112.235 -161.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.63 -3.94 90.3 Favored Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.206 -0.774 . . . . 0.0 113.085 171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 89.0 mmm -129.0 9.28 5.75 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.375 1.87 . . . . 0.0 111.84 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.1 mm -55.33 -45.64 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.831 1.252 . . . . 0.0 110.145 -177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -66.72 19.06 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.458 2.703 . . . . 0.0 113.551 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.156 0 C-N-CA 125.673 1.606 . . . . 0.0 114.486 -172.2 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.474 0.77 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt -60.45 -34.18 73.63 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 121.206 0.527 . . . . 0.0 110.468 171.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -63.3 -44.22 95.63 Favored 'General case' 0 C--O 1.226 -0.164 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.778 173.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.45 -48.67 41.27 Favored Glycine 0 CA--C 1.53 1.0 0 CA-C-O 119.013 -0.882 . . . . 0.0 111.553 167.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.32 -37.13 84.42 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.798 1.299 . . . . 0.0 112.529 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.285 96.8 mt -58.42 -92.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 126.991 2.116 . . . . 0.0 109.152 166.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.86 -37.05 8.18 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.819 2.048 . . . . 0.0 113.168 -171.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.01 -18.86 79.77 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.573 1.082 . . . . 0.0 113.967 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -76.87 -48.1 19.33 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.983 1.392 . . . . 0.0 108.796 161.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.8 mt -58.85 -43.61 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 125.322 1.449 . . . . 0.0 109.278 -173.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.74 -0.95 0.33 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 120.236 1.38 . . . . 0.0 114.4 -177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -122.62 -56.73 1.77 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.912 1.285 . . . . 0.0 110.45 159.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.79 -8.31 87.8 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.899 -0.945 . . . . 0.0 114.801 -166.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.46 ' HB2' HG23 ' A' ' 10' ' ' ILE . 18.6 t90 -55.59 -48.8 74.24 Favored 'General case' 0 CA--C 1.514 -0.439 0 C-N-CA 124.83 1.252 . . . . 0.0 111.018 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -75.42 -15.79 60.41 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.746 -159.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.3 -2.03 83.39 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 119.139 -0.812 . . . . 0.0 112.959 170.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 92.0 mmm -125.81 5.26 7.37 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.838 1.655 . . . . 0.0 111.973 -173.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mm -55.98 -45.09 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 124.696 1.199 . . . . 0.0 110.115 -178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.78 18.98 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.757 2.823 . . . . 0.0 113.972 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.141 0 C-N-CA 125.166 1.365 . . . . 0.0 114.48 -173.215 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.9 tt -58.42 -36.55 73.78 Favored 'General case' 0 C--O 1.225 -0.225 0 C-N-CA 123.043 0.537 . . . . 0.0 110.914 170.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -66.37 -41.07 89.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.814 177.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.46 -48.37 65.17 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 119.101 -0.833 . . . . 0.0 111.406 165.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.37 -32.05 73.37 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 118.586 1.193 . . . . 0.0 112.473 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.273 95.9 mt -60.63 -92.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 C-N-CA 126.774 2.03 . . . . 0.0 108.279 162.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -51.14 -39.28 55.91 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 126.231 1.813 . . . . 0.0 113.304 -165.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -73.92 -17.49 79.38 Favored Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.339 0.971 . . . . 0.0 113.549 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -81.17 -50.59 9.41 Favored 'General case' 0 C--N 1.339 0.112 0 CA-C-N 118.44 1.12 . . . . 0.0 108.737 162.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mt -56.63 -40.33 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 C-N-CA 125.694 1.598 . . . . 0.0 110.307 -173.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -60.01 -3.03 0.49 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 119.799 1.181 . . . . 0.0 113.96 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -123.97 -60.52 1.43 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.332 1.453 . . . . 0.0 110.385 159.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.32 2.62 84.36 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.535 1.064 . . . . 0.0 114.582 -164.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 16.8 t90 -53.31 -41.79 66.03 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 118.379 1.09 . . . . 0.0 111.543 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -63.04 -36.63 84.21 Favored 'General case' 0 CA--C 1.532 0.28 0 O-C-N 123.749 0.656 . . . . 0.0 111.269 -164.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.17 -1.11 62.86 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 119.013 -0.882 . . . . 0.0 113.798 176.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 10.3 mmt -119.48 3.33 11.25 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.08 1.752 . . . . 0.0 111.706 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -57.87 -48.72 83.19 Favored 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 123.782 0.833 . . . . 0.0 109.264 177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.51 19.35 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 128.334 2.654 . . . . 0.0 113.407 -177.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.152 0 C-N-CA 125.265 1.412 . . . . 0.0 114.711 -170.137 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 63.5 p . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -32.72 72.33 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 170.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -60.83 -47.01 88.29 Favored 'General case' 0 C--O 1.224 -0.282 0 C-N-CA 122.969 0.508 . . . . 0.0 110.774 172.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.37 -48.68 47.47 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 123.873 0.749 . . . . 0.0 111.565 169.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.02 -20.27 65.79 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 71.5 mt -86.12 -93.16 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 126.4 1.88 . . . . 0.0 108.004 168.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.12 -38.54 79.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 127.432 2.293 . . . . 0.0 112.614 -169.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.79 -38.73 66.15 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 119.13 0.877 . . . . 0.0 111.845 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -44.65 93.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.876 0.87 . . . . 0.0 110.419 167.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -64.01 -53.41 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 124.681 1.192 . . . . 0.0 108.754 -176.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -70.64 63.88 0.28 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.964 1.706 . . . . 0.0 111.626 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -178.9 -61.66 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 129.249 3.02 . . . . 0.0 108.646 -163.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.26 -4.27 4.09 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.059 1.314 . . . . 0.0 113.573 -168.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.525 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.3 t90 -46.38 -40.11 11.46 Favored 'General case' 0 CA--C 1.509 -0.607 0 C-N-CA 126.168 1.787 . . . . 0.0 110.807 170.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.07 -19.47 65.66 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.783 0.677 . . . . 0.0 112.106 -172.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.22 2.02 83.13 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.063 0.84 . . . . 0.0 112.959 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 11.6 mmt -128.2 6.54 5.9 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 127.083 2.153 . . . . 0.0 111.464 -174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.0 mm -55.95 -40.24 61.77 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.835 1.254 . . . . 0.0 109.85 177.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -63.83 17.87 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 129.77 3.228 . . . . 0.0 114.435 -176.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.108 0 C-N-CA 125.522 1.534 . . . . 0.0 114.153 -175.767 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 74.4 p . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.93 -34.16 72.86 Favored 'General case' 0 N--CA 1.464 0.24 0 C-N-CA 122.844 0.458 . . . . 0.0 110.321 170.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -62.83 -44.39 96.28 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 122.977 0.511 . . . . 0.0 110.672 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.52 -47.76 50.77 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.949 -0.917 . . . . 0.0 111.479 168.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.99 91.87 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.542 1.171 . . . . 0.0 112.434 177.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.287 96.6 mt -56.55 -92.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 126.884 2.073 . . . . 0.0 109.017 165.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.0 -37.26 3.91 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 127.403 2.281 . . . . 0.0 113.131 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.06 -28.37 73.0 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-N 119.683 1.129 . . . . 0.0 113.601 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.66 -39.04 67.45 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.899 1.35 . . . . 0.0 109.733 168.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -68.09 -49.7 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.282 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -175.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.39 55.91 0.82 Allowed 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 119.984 1.265 . . . . 0.0 110.634 -174.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.63 -67.62 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 131.666 3.986 . . . . 0.0 107.234 -161.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -116.54 -5.38 16.4 Favored Glycine 0 C--N 1.345 1.067 0 C-N-CA 124.65 1.119 . . . . 0.0 114.284 -166.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.521 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.0 t90 -48.02 -45.45 31.9 Favored 'General case' 0 CA--C 1.507 -0.692 0 C-N-CA 125.717 1.607 . . . . 0.0 109.854 172.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -67.84 -23.96 65.22 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 124.525 1.141 . . . . 0.0 111.441 -166.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.09 -10.05 80.83 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 118.583 -1.121 . . . . 0.0 113.268 175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.4 mmm -122.07 12.61 10.39 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.503 1.521 . . . . 0.0 111.942 -173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.0 mm -73.39 -51.29 26.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 2.8 p30 32.3 13.78 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.892 1 C-N-CA 134.191 4.997 . . . . 0.0 120.689 171.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.059 0 C-N-CA 126.401 1.953 . . . . 0.0 113.602 -179.866 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 65.8 p . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.05 -32.56 72.19 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 170.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -59.33 -46.67 87.96 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.151 0.58 . . . . 0.0 110.889 172.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.93 -44.13 55.67 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 119.088 -0.84 . . . . 0.0 111.99 170.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.73 -32.37 73.63 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 118.742 1.271 . . . . 0.0 112.718 176.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 94.0 mt -70.36 -92.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.819 2.047 . . . . 0.0 108.571 171.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.49 -43.26 55.55 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.506 1.922 . . . . 0.0 111.567 -172.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.78 -21.78 73.3 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.583 -177.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -71.75 -51.14 24.31 Favored 'General case' 0 C--N 1.342 0.249 0 CA-C-N 119.134 1.467 . . . . 0.0 109.079 165.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.417 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.5 mt -55.07 -44.01 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.794 0 C-N-CA 125.733 1.613 . . . . 0.0 109.019 -177.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.49 -3.98 0.13 Allowed 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.433 1.493 . . . . 0.0 114.278 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.53 -56.25 1.4 Allowed 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.171 1.389 . . . . 0.0 110.849 158.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -78.86 -7.28 88.4 Favored Glycine 0 CA--C 1.527 0.838 0 CA-C-O 118.876 -0.958 . . . . 0.0 114.398 -166.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.417 ' HB2' HG23 ' A' ' 10' ' ' ILE . 20.5 t90 -53.56 -51.44 62.91 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 124.668 1.187 . . . . 0.0 110.852 177.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -71.81 -20.08 61.9 Favored 'General case' 0 CA--C 1.533 0.308 0 O-C-N 123.918 0.761 . . . . 0.0 111.638 -163.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.43 -5.94 89.55 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.409 -1.217 . . . . 0.0 113.209 172.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.3 mmm -128.1 16.3 6.73 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 126.425 1.89 . . . . 0.0 111.838 -173.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 6.8 mm -62.87 -31.3 51.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 C-N-CA 123.894 0.878 . . . . 0.0 110.802 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 49.57 14.38 0.11 Allowed 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 129.96 3.304 . . . . 0.0 117.156 165.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.983 0 C-N-CA 125.118 1.342 . . . . 0.0 113.641 -174.916 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.9 p . . . . . 0 N--CA 1.474 0.769 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.87 -34.78 73.59 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 122.711 0.404 . . . . 0.0 110.119 170.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -61.82 -45.64 92.95 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 122.65 0.38 . . . . 0.0 110.689 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.98 -48.79 37.67 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.174 0.892 . . . . 0.0 111.609 168.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.51 -33.78 76.33 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 118.233 1.016 . . . . 0.0 112.784 177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.257 96.5 mt -65.27 -92.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 C-N-CA 126.59 1.956 . . . . 0.0 108.555 167.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.54 -39.36 48.95 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 126.527 1.931 . . . . 0.0 112.318 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.32 -22.86 77.68 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.702 -1.054 . . . . 0.0 113.574 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -71.75 -48.25 48.1 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-N 119.16 1.48 . . . . 0.0 109.076 164.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.484 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.8 mt -59.19 -45.36 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 C-N-CA 125.213 1.405 . . . . 0.0 108.822 -173.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -61.89 4.72 0.11 Allowed 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 120.106 1.321 . . . . 0.0 114.252 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -126.86 -54.85 1.4 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.721 1.608 . . . . 0.0 109.872 158.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.82 -10.74 84.73 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 118.967 -0.907 . . . . 0.0 114.496 -167.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.484 ' HB2' HG23 ' A' ' 10' ' ' ILE . 19.3 t90 -56.86 -53.53 56.86 Favored 'General case' 0 CA--C 1.513 -0.468 0 C-N-CA 125.169 1.388 . . . . 0.0 110.429 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -69.83 -29.61 66.92 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 123.902 0.751 . . . . 0.0 110.745 -161.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.31 4.84 46.93 Favored Glycine 0 CA--C 1.532 1.098 0 CA-C-O 118.242 -1.31 . . . . 0.0 113.832 174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 70.2 mtp -132.9 11.83 4.32 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.317 1.447 . . . . 0.0 112.204 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 13.8 mm -65.73 -36.26 77.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-N 119.219 0.918 . . . . 0.0 110.474 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 47.82 15.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 130.65 3.58 . . . . 0.0 117.537 164.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.925 0 C-N-CA 124.854 1.216 . . . . 0.0 113.299 -171.882 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.3 p . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.15 -30.85 71.89 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 171.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -56.7 -43.76 80.84 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.436 0.695 . . . . 0.0 110.676 170.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.34 -21.12 46.97 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.875 1.226 . . . . 0.0 114.313 172.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -94.25 -19.96 20.24 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 119.634 1.717 . . . . 0.0 112.322 173.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 77.1 mt -86.1 -93.52 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 127.009 2.124 . . . . 0.0 107.126 173.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.74 -43.14 80.41 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 126.117 1.767 . . . . 0.0 110.397 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.29 -21.17 71.97 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 118.99 -0.894 . . . . 0.0 113.682 -177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -76.51 -52.42 9.81 Favored 'General case' 0 C--N 1.341 0.198 0 CA-C-N 118.781 1.291 . . . . 0.0 109.427 165.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.7 mt -54.87 -41.69 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 C-N-CA 126.048 1.739 . . . . 0.0 109.382 -173.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -59.1 -2.65 0.28 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.15 -56.61 1.43 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.54 1.536 . . . . 0.0 110.504 158.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.79 -2.67 88.62 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 124.283 0.944 . . . . 0.0 114.609 -166.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.477 ' HB2' HG23 ' A' ' 10' ' ' ILE . 18.0 t90 -57.08 -49.02 77.15 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 118.471 1.135 . . . . 0.0 110.947 177.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -67.26 -33.72 75.93 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 123.686 0.616 . . . . 0.0 110.937 -163.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.86 4.48 45.14 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.436 -1.202 . . . . 0.0 113.665 174.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -133.13 12.99 4.26 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.216 1.806 . . . . 0.0 111.463 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 5.9 mm -61.48 -38.37 79.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 O-C-N 121.344 -0.848 . . . . 0.0 110.427 178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 48.04 14.8 0.06 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 130.362 3.465 . . . . 0.0 117.275 166.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.896 0 C-N-CA 125.794 1.664 . . . . 0.0 113.888 -172.685 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.72 -32.76 72.01 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 169.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -64.13 -46.89 82.16 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.877 -0.515 . . . . 0.0 110.705 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.46 -49.43 39.13 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 123.983 0.801 . . . . 0.0 111.237 169.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.95 -35.05 78.86 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 117.995 0.898 . . . . 0.0 112.581 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.267 74.7 mt -63.63 -92.69 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 C-N-CA 126.78 2.032 . . . . 0.0 108.575 167.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.45 -41.45 20.5 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.854 2.062 . . . . 0.0 112.091 -169.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.8 -25.39 71.79 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 119.832 1.196 . . . . 0.0 113.916 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -74.31 -41.24 61.48 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 118.898 1.349 . . . . 0.0 109.849 169.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.525 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -64.94 -48.05 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 C-N-CA 124.959 1.304 . . . . 0.0 108.03 -178.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -70.7 42.65 0.06 Allowed 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 127.044 2.137 . . . . 0.0 112.633 -174.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -160.7 -65.46 0.06 Allowed 'General case' 0 N--CA 1.452 -0.358 1 C-N-CA 132.664 4.386 . . . . 0.0 106.805 -176.712 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -110.91 -7.25 25.56 Favored Glycine 0 C--N 1.346 1.094 0 CA-C-O 118.931 -0.927 . . . . 0.0 114.201 -165.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.525 ' HB2' HG23 ' A' ' 10' ' ' ILE . 19.6 t90 -47.82 -43.87 28.35 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 125.336 1.454 . . . . 0.0 110.553 174.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.03 -12.34 60.59 Favored 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.021 0.826 . . . . 0.0 111.987 -166.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -91.38 -0.65 72.99 Favored Glycine 0 CA--C 1.533 1.207 0 C-N-CA 123.999 0.809 . . . . 0.0 112.867 168.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 91.8 mmm -129.59 8.86 5.43 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.095 2.158 . . . . 0.0 111.922 -171.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.402 ' C ' ' H ' ' A' ' 20' ' ' GLY . 2.9 mm -53.95 -38.0 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 C-N-CA 125.203 1.401 . . . . 0.0 110.289 -177.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -66.6 13.89 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.7 2.0 . . . . 0.0 113.803 179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 18' ' ' ILE . . . . . . . . 0 CA--C 1.535 1.293 0 C-N-CA 128.4 2.905 . . . . 0.0 111.869 174.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.29 -33.65 73.91 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.785 0.326 . . . . 0.0 110.328 172.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -63.61 -44.42 94.01 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 122.731 0.413 . . . . 0.0 110.933 174.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.61 -49.06 47.98 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.207 168.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.32 -36.77 83.18 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.06 0.93 . . . . 0.0 112.521 178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.293 90.1 mt -57.11 -92.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 C-N-CA 126.957 2.103 . . . . 0.0 108.953 164.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.05 -38.26 7.72 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 126.773 2.029 . . . . 0.0 113.064 -170.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -70.5 -25.06 76.28 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 118.849 -0.973 . . . . 0.0 113.829 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -74.81 -36.86 62.45 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.033 1.416 . . . . 0.0 110.004 168.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.459 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -70.02 -54.59 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 C-N-CA 125.148 1.379 . . . . 0.0 108.537 -174.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -70.4 69.54 0.39 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.487 1.915 . . . . 0.0 110.906 -172.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -176.34 -59.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 127.694 2.398 . . . . 0.0 108.689 -160.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -155.09 4.81 0.24 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.123 1.344 . . . . 0.0 112.863 -164.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.459 ' HB2' HG23 ' A' ' 10' ' ' ILE . 10.5 t90 -43.15 -38.95 2.64 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 126.391 1.876 . . . . 0.0 111.481 165.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.77 -34.05 77.02 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 120.366 -0.533 . . . . 0.0 110.916 -176.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.5 -9.4 73.58 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 124.577 1.084 . . . . 0.0 113.049 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 81.2 mmm -102.18 3.84 38.81 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.428 1.491 . . . . 0.0 111.232 169.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -104.57 -80.13 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 171.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -150.15 14.04 0.79 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.644 1.178 . . . . 0.0 112.051 -173.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.907 0 C-N-CA 125.253 1.406 . . . . 0.0 114.24 -167.146 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.0 p . . . . . 0 N--CA 1.473 0.723 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.38 -32.86 71.7 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 122.637 0.375 . . . . 0.0 110.088 170.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -61.81 -47.2 86.2 Favored 'General case' 0 CA--C 1.519 -0.231 0 C-N-CA 123.048 0.539 . . . . 0.0 110.841 173.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.88 -49.94 33.84 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.059 0.838 . . . . 0.0 111.342 168.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.42 -21.49 66.33 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 118.187 0.993 . . . . 0.0 113.542 177.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.25 77.4 mt -82.24 -92.87 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 126.941 2.096 . . . . 0.0 107.708 169.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.66 -39.56 17.56 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 127.3 2.24 . . . . 0.0 112.933 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.01 -14.42 82.24 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 123.993 0.806 . . . . 0.0 113.715 -179.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -45.55 13.41 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 118.462 1.131 . . . . 0.0 108.551 163.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.427 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.8 mt -58.29 -42.91 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 C-N-CA 125.369 1.468 . . . . 0.0 109.2 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -60.14 0.11 0.19 Allowed 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.29 -55.29 1.45 Allowed 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.306 1.442 . . . . 0.0 110.545 159.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.41 -9.05 87.07 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.12 -0.822 . . . . 0.0 114.535 -166.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.427 ' HB2' HG23 ' A' ' 10' ' ' ILE . 22.5 t90 -59.87 -56.0 27.15 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 124.905 1.282 . . . . 0.0 111.004 177.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -70.73 -25.64 63.02 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.887 -158.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -77.44 -1.43 76.03 Favored Glycine 0 CA--C 1.533 1.206 0 CA-C-O 118.555 -1.136 . . . . 0.0 113.698 173.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.3 mtm -135.95 22.49 3.3 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 126.061 1.745 . . . . 0.0 111.476 -175.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.7 mm -63.03 -34.79 68.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 124.084 0.954 . . . . 0.0 110.709 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 48.9 14.29 0.07 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 130.107 3.363 . . . . 0.0 117.055 168.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 C-N-CA 126.005 1.764 . . . . 0.0 113.663 -175.575 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 73.1 p . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.12 -32.43 73.01 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 171.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -62.78 -45.75 91.22 Favored 'General case' 0 CA--C 1.519 -0.245 0 O-C-N 121.936 -0.478 . . . . 0.0 110.701 173.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.34 -48.92 39.91 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.189 0.9 . . . . 0.0 111.53 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.21 -32.55 73.22 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 118.577 1.188 . . . . 0.0 112.67 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.262 68.5 mt -68.75 -92.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 126.869 2.068 . . . . 0.0 108.585 169.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.51 -38.49 20.37 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 127.082 2.153 . . . . 0.0 113.117 -172.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.5 -17.26 79.84 Favored Glycine 0 CA--C 1.53 1.002 0 C-N-CA 124.065 0.84 . . . . 0.0 113.818 -178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -78.34 -50.02 12.55 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 118.79 1.295 . . . . 0.0 108.639 161.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 mt -56.88 -41.82 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 125.284 1.434 . . . . 0.0 110.115 -173.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -60.17 -1.63 0.34 Allowed 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.207 1.367 . . . . 0.0 114.459 -178.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.13 -58.04 1.38 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.002 1.321 . . . . 0.0 110.575 159.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -77.88 -6.87 87.43 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 118.892 -0.949 . . . . 0.0 114.392 -165.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 21.7 t90 -54.14 -52.78 60.01 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 124.616 1.167 . . . . 0.0 111.01 177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -70.36 -22.65 62.76 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 123.843 0.714 . . . . 0.0 111.495 -162.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.7 -0.59 89.51 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.36 -1.244 . . . . 0.0 113.446 173.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 39.1 mtt -137.96 23.05 2.84 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.619 1.568 . . . . 0.0 111.31 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mm -58.58 -39.8 76.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 124.503 1.121 . . . . 0.0 110.929 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 46.59 14.27 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 130.977 3.711 . . . . 0.0 117.602 167.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.065 0 C-N-CA 125.58 1.562 . . . . 0.0 114.044 -176.81 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.21 -37.77 75.47 Favored 'General case' 0 C--O 1.225 -0.225 0 CA-C-O 121.229 0.538 . . . . 0.0 110.267 169.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -58.83 -45.17 90.65 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.219 0.533 . . . . 0.0 110.529 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -54.82 -36.09 59.33 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.703 1.144 . . . . 0.0 113.067 170.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.21 -27.5 53.5 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 119.377 1.589 . . . . 0.0 112.579 174.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.2 mt -85.99 -93.45 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 126.398 1.879 . . . . 0.0 108.461 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.13 -38.22 76.09 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 126.034 1.734 . . . . 0.0 110.631 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.02 -22.52 75.93 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.862 -0.965 . . . . 0.0 113.463 -179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -72.81 -48.96 33.55 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 119.009 1.405 . . . . 0.0 109.165 165.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.546 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.9 mt -58.91 -44.63 91.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 C-N-CA 125.314 1.446 . . . . 0.0 108.729 -173.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -64.72 9.47 0.09 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 120.317 1.417 . . . . 0.0 114.099 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.13 -56.4 1.26 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.908 2.083 . . . . 0.0 109.364 158.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.1 -9.68 84.87 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 119.254 -0.748 . . . . 0.0 114.67 -166.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.546 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.2 t90 -58.01 -45.89 86.15 Favored 'General case' 0 CA--C 1.511 -0.534 0 C-N-CA 125.213 1.405 . . . . 0.0 110.988 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -66.44 -32.8 74.39 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 123.842 0.714 . . . . 0.0 111.035 -163.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.71 1.69 51.87 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 118.626 -1.097 . . . . 0.0 113.687 174.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -131.42 15.16 5.01 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.401 1.88 . . . . 0.0 111.212 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.2 mm -67.03 -44.62 88.2 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 O-C-N 121.326 -0.859 . . . . 0.0 109.486 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 51.48 15.27 0.32 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 128.086 2.555 . . . . 0.0 115.786 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.072 0 C-N-CA 125.582 1.563 . . . . 0.0 113.933 -174.655 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 71.0 p . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.83 -32.6 71.98 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 170.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -62.77 -47.28 84.17 Favored 'General case' 0 CA--C 1.518 -0.253 0 O-C-N 122.035 -0.416 . . . . 0.0 110.81 173.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.16 -48.9 38.67 Favored Glycine 0 CA--C 1.53 1.024 0 O-C-N 123.98 0.8 . . . . 0.0 111.254 169.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.35 77.62 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 117.924 0.862 . . . . 0.0 112.764 178.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.268 70.8 mt -62.55 -92.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 C-N-CA 126.82 2.048 . . . . 0.0 108.492 166.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.81 -40.51 29.45 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 126.707 2.003 . . . . 0.0 112.48 -169.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.07 -30.14 77.19 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 119.737 1.153 . . . . 0.0 113.377 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -37.61 83.09 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 118.711 1.256 . . . . 0.0 110.107 171.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mt -69.02 -54.4 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 C-N-CA 125.211 1.404 . . . . 0.0 108.678 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -66.82 59.82 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 129.16 2.984 . . . . 0.0 112.291 -173.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -172.18 -64.86 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 127.745 2.418 . . . . 0.0 108.603 -162.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -140.53 -1.9 1.59 Allowed Glycine 0 CA--C 1.528 0.847 0 C-N-CA 124.89 1.233 . . . . 0.0 113.412 -166.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 9.4 t90 -40.37 -45.91 2.26 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 126.086 1.754 . . . . 0.0 111.189 168.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.75 -14.97 62.64 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 124.2 0.937 . . . . 0.0 112.071 -170.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -92.48 4.37 76.48 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 124.449 1.023 . . . . 0.0 112.806 170.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.9 mtm -135.04 17.6 3.47 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.083 2.153 . . . . 0.0 111.118 -175.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.8 mm -60.76 -35.73 66.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 124.944 1.298 . . . . 0.0 110.863 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 45.03 14.64 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 131.447 3.899 . . . . 0.0 118.005 165.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.072 0 C-N-CA 125.308 1.432 . . . . 0.0 114.004 -178.007 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.0 p . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.48 -33.6 72.83 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 171.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.5 -47.08 85.53 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 122.682 0.393 . . . . 0.0 110.815 173.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -52.14 -46.12 56.7 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-O 119.049 -0.862 . . . . 0.0 111.404 170.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.66 -35.88 82.0 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.474 1.137 . . . . 0.0 112.459 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.276 86.0 mt -60.35 -92.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 126.635 1.974 . . . . 0.0 108.568 165.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -45.67 -40.4 9.11 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 127.281 2.232 . . . . 0.0 112.568 -170.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -65.23 -28.95 74.16 Favored Glycine 0 CA--C 1.533 1.182 0 CA-C-N 119.859 1.208 . . . . 0.0 113.673 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -69.56 -37.7 77.13 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 118.935 1.367 . . . . 0.0 109.906 170.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.428 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.7 mt -68.3 -52.47 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 C-N-CA 125.026 1.331 . . . . 0.0 108.431 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.62 54.56 0.08 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 128.176 2.59 . . . . 0.0 112.357 -173.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -175.03 -69.09 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 129.558 3.143 . . . . 0.0 108.038 -163.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -122.13 -4.71 9.17 Favored Glycine 0 C--N 1.344 0.992 0 C-N-CA 124.792 1.187 . . . . 0.0 113.852 -167.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.428 ' HB2' HG23 ' A' ' 10' ' ' ILE . 16.1 t90 -44.04 -45.14 7.82 Favored 'General case' 0 CA--C 1.507 -0.71 0 C-N-CA 125.964 1.706 . . . . 0.0 111.097 171.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.08 -11.14 60.44 Favored 'General case' 0 CA--C 1.538 0.508 0 O-C-N 124.073 0.858 . . . . 0.0 112.067 -169.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -93.93 2.64 69.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 124.212 0.911 . . . . 0.0 112.797 168.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 21.9 mmt -130.6 8.04 4.91 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.697 1.999 . . . . 0.0 111.474 -172.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 4.2 mm -55.29 -41.12 59.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.323 1.449 . . . . 0.0 110.166 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -64.3 16.17 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 129.543 3.137 . . . . 0.0 114.683 -173.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.191 0 C-N-CA 125.782 1.658 . . . . 0.0 113.535 178.396 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 76.1 p . . . . . 0 N--CA 1.473 0.72 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.77 -33.13 72.49 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.171 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -63.93 -45.49 89.0 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 122.587 0.355 . . . . 0.0 110.715 173.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -49.86 -47.9 38.43 Favored Glycine 0 CA--C 1.53 1.021 0 CA-C-O 118.902 -0.943 . . . . 0.0 111.451 168.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.16 -41.86 98.71 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.587 1.193 . . . . 0.0 112.303 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.295 89.9 mt -54.88 -92.49 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 127.157 2.183 . . . . 0.0 109.391 167.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -44.62 -42.15 7.2 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.604 1.961 . . . . 0.0 112.622 -174.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.35 -26.63 74.15 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-O 118.618 -1.101 . . . . 0.0 113.573 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -69.07 -50.45 48.26 Favored 'General case' 0 C--N 1.341 0.234 0 CA-C-N 119.266 1.533 . . . . 0.0 109.036 165.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mt -56.6 -42.8 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.896 0 C-N-CA 125.262 1.425 . . . . 0.0 109.369 -175.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -59.16 -2.25 0.26 Allowed 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 113.961 1.097 . . . . 0.0 113.961 -178.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -127.0 -57.7 1.31 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.109 1.363 . . . . 0.0 110.748 159.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.87 -5.05 89.64 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 118.882 -0.954 . . . . 0.0 114.414 -165.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.7 t90 -55.61 -53.68 53.48 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 118.545 1.172 . . . . 0.0 110.881 174.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -72.01 -24.46 61.57 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.342 -164.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.69 10.96 28.69 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.503 1.525 . . . . 0.0 113.593 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 14.0 mmt -124.65 -10.95 7.31 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.828 1.251 . . . . 0.0 112.786 165.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 2.5 mm -75.41 -26.57 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.212 1.405 . . . . 0.0 110.91 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -68.84 16.46 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 127.63 2.372 . . . . 0.0 112.954 172.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.223 0 C-N-CA 125.719 1.628 . . . . 0.0 114.305 -175.77 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.6 p . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.2 tt -60.09 -34.31 73.29 Favored 'General case' 0 CA--C 1.529 0.173 0 C-N-CA 123.121 0.569 . . . . 0.0 110.751 171.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -62.93 -45.63 91.59 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.786 173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.43 -48.14 49.28 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 119.012 -0.882 . . . . 0.0 111.295 168.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.37 -34.24 77.29 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 118.491 1.146 . . . . 0.0 112.852 178.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.28 96.5 mt -60.72 -92.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 C-N-CA 126.693 1.997 . . . . 0.0 108.648 164.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.45 -36.99 7.14 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 127.165 2.186 . . . . 0.0 113.266 -170.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.16 -26.21 72.79 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-N 119.453 1.024 . . . . 0.0 113.703 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -70.61 -38.15 73.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 119.118 1.459 . . . . 0.0 109.46 167.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -65.17 -56.19 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.933 0 C-N-CA 124.937 1.295 . . . . 0.0 110.141 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -68.86 65.38 0.13 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 128.83 2.852 . . . . 0.0 110.691 -175.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -171.94 -51.33 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 126.349 1.86 . . . . 0.0 109.017 -163.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -158.88 -4.19 0.07 OUTLIER Glycine 0 C--N 1.34 0.775 0 CA-C-O 117.604 -1.665 . . . . 0.0 115.011 -169.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.548 ' NE1' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -57.81 -36.62 72.47 Favored 'General case' 0 C--N 1.345 0.408 0 CA-C-N 120.162 1.981 . . . . 0.0 110.042 173.18 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -61.4 -29.82 70.17 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.489 -173.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.21 7.72 21.61 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.857 1.218 . . . . 0.0 113.845 177.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 48.0 mtt -130.53 6.62 4.81 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.26 1.424 . . . . 0.0 111.879 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.548 HD11 ' NE1' ' A' ' 14' ' ' TRP . 29.3 mm -72.63 -34.07 46.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.974 0.91 . . . . 0.0 111.21 -175.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 50.11 17.27 0.3 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 129.605 3.162 . . . . 0.0 116.091 167.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.994 0 C-N-CA 125.86 1.695 . . . . 0.0 113.666 -173.08 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.1 p . . . . . 0 N--CA 1.475 0.795 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -62.57 -32.78 73.81 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 170.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -55.58 -45.68 77.33 Favored 'General case' 0 N--CA 1.463 0.193 0 C-N-CA 123.695 0.798 . . . . 0.0 110.872 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.23 -24.37 55.15 Favored Glycine 0 CA--C 1.535 1.343 0 CA-C-O 118.581 -1.122 . . . . 0.0 114.04 172.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.83 -18.1 30.05 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 119.571 1.686 . . . . 0.0 112.356 172.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 85.0 mt -86.29 -93.25 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 126.951 2.1 . . . . 0.0 107.474 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.28 -45.5 72.48 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.372 1.869 . . . . 0.0 110.522 -176.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.3 -13.61 65.25 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-N 119.004 0.82 . . . . 0.0 114.272 -178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -83.03 -46.28 13.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 118.754 1.277 . . . . 0.0 109.583 164.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -54.76 -51.94 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 126.058 1.743 . . . . 0.0 111.171 178.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -67.1 47.87 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 130.871 3.668 . . . . 0.0 113.314 -171.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -145.17 -56.06 0.32 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 127.193 2.197 . . . . 0.0 109.296 -172.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -146.36 -4.82 0.45 Allowed Glycine 0 C--N 1.341 0.822 0 CA-C-O 118.047 -1.418 . . . . 0.0 114.112 -170.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.547 ' NE1' HD11 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -57.29 -31.51 65.71 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 119.589 1.694 . . . . 0.0 110.756 173.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.92 -30.67 68.01 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.88 0.872 . . . . 0.0 111.748 -174.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -74.71 8.91 12.31 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.574 -1.126 . . . . 0.0 113.905 176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 49.6 mtt -130.5 5.89 4.77 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.693 1.597 . . . . 0.0 112.001 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.547 HD11 ' NE1' ' A' ' 14' ' ' TRP . 25.6 mm -73.69 -31.69 32.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 C-N-CA 124.084 0.954 . . . . 0.0 111.417 -175.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 49.75 14.48 0.12 Allowed 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 130.416 3.486 . . . . 0.0 117.159 164.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.003 0 C-N-CA 125.708 1.623 . . . . 0.0 114.022 -174.979 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.4 tt -59.96 -35.15 74.34 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.007 0.432 . . . . 0.0 110.472 171.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -62.31 -46.02 90.61 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.635 173.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.0 -46.8 49.98 Favored Glycine 0 CA--C 1.531 1.059 0 CA-C-O 118.989 -0.895 . . . . 0.0 111.487 168.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.08 -34.83 78.93 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 118.671 1.236 . . . . 0.0 112.652 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . 0.274 97.2 mt -61.86 -92.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 126.811 2.044 . . . . 0.0 109.023 166.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -47.24 -42.75 21.02 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.333 1.853 . . . . 0.0 112.077 -171.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -69.27 -23.24 76.38 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-N 119.573 1.079 . . . . 0.0 113.612 -178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -70.62 -49.17 50.46 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 119.153 1.477 . . . . 0.0 108.992 165.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.426 HG23 ' HB2' ' A' ' 14' ' ' TRP . 1.7 mt -55.23 -45.54 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 125.293 1.437 . . . . 0.0 108.932 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -57.11 -1.21 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.59 1.556 . . . . 0.0 114.36 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -125.29 -56.61 1.52 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.123 1.369 . . . . 0.0 110.334 158.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.11 -8.33 87.47 Favored Glycine 0 CA--C 1.529 0.917 0 CA-C-O 119.056 -0.858 . . . . 0.0 114.666 -165.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.727 ' CD1' HD11 ' A' ' 18' ' ' ILE . 21.6 t90 -53.45 -57.0 12.21 Favored 'General case' 0 CA--C 1.511 -0.528 0 C-N-CA 125.526 1.53 . . . . 0.0 110.381 175.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.599 ' HA ' HD13 ' A' ' 18' ' ' ILE . 47.6 mt-10 -70.32 3.49 2.88 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -158.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -98.15 2.24 59.53 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-O 118.331 -1.26 . . . . 0.0 113.644 166.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.8 mtm -125.7 -7.52 6.78 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 119.428 1.614 . . . . 0.0 115.344 -167.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.727 HD11 ' CD1' ' A' ' 14' ' ' TRP . 3.0 mp -65.9 -37.87 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 C-N-CA 124.835 1.254 . . . . 0.0 110.294 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.95 22.3 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 129.425 3.09 . . . . 0.0 114.161 -172.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.1 0 C-N-CA 125.217 1.389 . . . . 0.0 114.527 -173.47 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 59.3 p . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.7 tt -58.08 -36.81 73.38 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.073 0.549 . . . . 0.0 110.572 168.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -60.24 -46.16 90.74 Favored 'General case' 0 C--O 1.224 -0.256 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.719 173.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -50.85 -46.5 48.88 Favored Glycine 0 CA--C 1.531 1.066 0 CA-C-O 118.957 -0.913 . . . . 0.0 112.074 169.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.01 -25.27 67.78 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 118.773 1.286 . . . . 0.0 113.039 176.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.12 -92.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 C-N-CA 126.662 1.985 . . . . 0.0 107.972 167.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -46.81 -42.06 16.51 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.542 2.337 . . . . 0.0 112.615 -171.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.65 -14.4 77.86 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 119.409 1.004 . . . . 0.0 113.943 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.36 -40.5 23.43 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 118.77 1.285 . . . . 0.0 109.462 163.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.58 -53.05 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 C-N-CA 125.449 1.5 . . . . 0.0 111.293 -179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -67.3 64.03 0.06 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.824 2.85 . . . . 0.0 111.949 -172.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.1 m-80 -160.54 -54.53 0.05 Allowed 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 126.817 2.047 . . . . 0.0 110.02 -167.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -167.46 10.58 0.06 OUTLIER Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.593 -1.115 . . . . 0.0 113.391 -171.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.64 -20.29 46.55 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.455 1.627 . . . . 0.0 111.753 172.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 mp0 -54.36 -31.69 55.23 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.863 1.265 . . . . 0.0 111.368 173.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -64.57 -11.26 47.72 Favored Glycine 0 CA--C 1.536 1.375 0 O-C-N 121.51 -0.744 . . . . 0.0 113.507 173.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 94.0 mmm -109.54 -3.63 16.81 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.46 1.904 . . . . 0.0 112.243 171.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.1 mt -84.99 -37.85 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.296 1.438 . . . . 0.0 108.637 167.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -69.06 71.14 0.23 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.421 1.489 . . . . 0.0 110.871 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 C-N-CA 125.478 1.513 . . . . 0.0 110.625 178.001 . . . . . . . . 0 0 . 1 stop_ save_